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CHAPTER I 
 
INTRODUCTION 
 
The Siddha system is considered as “Karpa viriksha” a desire tree as it holds all 
things experiential by man it deals with all existence however the medicinal dimension is 
considered as the first vital door to this mystic tradition and shines as its hallmark. It is the 
first system to emphasize health as the ideal perfected state of physical, psychological, 
social and spiritual component of a human being to prolong life 
 
The siddha system depends on basic elements of earth, water, air, fire and space 
which forms a human body. Additionally, there are three doshas namely vatha (Air), pitha 
(bile), kapha (phlegm) are the fundamental principles which exists in all the cells regulating 
all the functions in our body and maintaining the balance in the physical, emotional and 
mental spheres. 
 
Siddhars laid the foundation of this medical system. Among them Eighteen siddhars 
were said to contribute towards the development of this system. The father figure of siddha 
medicine, literature, grammar and above all of profound wisdom is the siddha Agasthiyar. 
The concept of siddhars were that a healthy soul can only be developed through healthy 
body. 
 
Siddha system plays a major role in the field of paediatrics to cure disease. Because, 
childrens are the most vulnerable group in the society. They can be affected easily due to 
under developed immune system and they are exposed to several pathogen from 
surroundings. Many siddhars have been described paediatric disease in volumes and 
volumes of book like Balavagadam, Agathiyar pillai Tamil  etc…ensured in order to cure 
diseases in childrens. 
 
  Mantham is one of the purakarana noigal (Diseases due to external factors) and 
commonly occurring disease in childrens. There are 21 types of mantham where listed in 
Balavagadam text book, Among those Kattu mantham occurs in children between the age of 
1-3 years. It affects both male and female children with the symptoms of poor appetite, 
stomach pain/borborygmus, constipation sometimes with or without the symptoms of 
cough, fever and yawning. Kattu mantham may nearly be compared with Constipation of 
modern medicine. 
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 Typically constipation develops during three stages of childhood namely during 
weaning in toddlers, during toilet training and in school age. The symptoms of constipation 
are abdominal pain, poor appetite, borborygmus, feeling sick. Child needs to go to the toilet 
but not passing stools and having painful micturition.  
  
 Epideomological studies says that the children affecting from constipation in 
childhood with the percentage of 0.7% and 29.6% (average of 12%). In the Out patient 
department of Ayothidoss Pandithar hospital, National Institute of Siddha around 2500 
patients are visiting every day for treatment for various ailments. Among them, 3 - 5% of 
patients are in paediatric group and many patients are reporting with constipation problem. 
  
In the text book of Balavagadam, authored by K.S.Murugesa mudhaliyar a sastric 
siddha medicine named “CHUKKU NEI” have been indicated for KATTU MANTHAM 
and “CHINNI THUVALAI” (external) also described in the same text book indicated for all 
types of mantham. These medicines were used only for 3 days. 
 
The ingredients of this trial drug used commonly in various formulation and 
“CHUKKU NEI” and “CHINNI THUVALAI” is believed to be effective in the 
management of  KATTU MANTHAM, but the scientific validation and proper clinical trial 
have not been done so far. 
 
Hence the author selected “CHUKKU NEI” (internal) and “CHINNI THUVALAI” 
(external) in the treatment of KATTU MANTHAM as a dissertation study and discussed the 
topic on the basics of siddha concept as well as the modern aspect and about the treatment, 
prognosis  and diatetic aspects. 
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CHAPTER  II 
 
2. AIMS AND OBJECTIVES: 
Primary Aim and Objectives: 
 
To evaluate the efficacy of Chukku nei as internal medicine and Chinni thuvalai as external 
in the management of Kattu mantham in Children under the following preclinical and 
clinical parameters 
 Physicochemical Analysis, Phytochemical Analaysis, Bio chemical Analysis, 
Phamacological studies of trial drug 
 Clinical trial study in Kattu mantham affected children. 
 
Secondary objectives: 
 To collect and review the ideas mentioned in the ancient Siddha literature 
about the disease Kattu mantham. 
 To explore Definition, Etiology, Clinical features, Investigations, Diagnosis 
and treatment of Kattu mantham as laid down from various siddha literature. 
 To explore the characteristics of kattu mantham with that of constipation as 
per siddha literature.  
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CHAPTER  III 
 
 
3. REVIEW OF LITERATURE 
   3.1 SIDDHA ASPECT 
khe;jk; 
NtWngah;fs; 
ke;jk;> myrk>; myrfk; vd gps;isg; gpzp kUj;Jt Ehypy; Fwpg;gplg;gl;Ls;sJ.  
 
,a;y 
 ke;j ,ay;GilaJ khe;jk; vdg;gL;k;. ke;jk; vd;gJ cUt 
epiyap;y;cly;epiyapy; ke;jk;. mUtepiyapy; mff;fUtpfshfpa kdk;> Gj;jp> 
rpj;jk;> mfq;fhuk; Mfpa midj;J me;;j fuzq;fspYk; ke;jk; vd Foe;ij  
kUj;Jtj;jpy; nfhLf;fg;gl;Ls;sJ.   
 cz;l czT nrhpahky; tapw;wpy; Gspj;J tapW cg;gp ,iue;J  ke;jj;ij 
cz;lhf;fp the;jpiaAk; fopr;riyAk; cz;lhf;fp Jd;gj;ij Vw;gLj;Jk; Neha; vd 
gps;isg; gpzpkUj;Jtj;jpy; Fwpg;gplg;gl;Ls;sJ. 
 
Neha; tUk; gUtk;: 
 jhyg;gUtk;> rg;ghzpg; gUtk;> Kj;jg; gUtk;> tUifg; gUtq;fspy; 
cz;lhf;f$ba NehahFk;. Foe;ijapd; Kjy; Mz;by; ,Ue;J %d;W Mz;Lfs; 
tiu njhlUk; vd Foe;ij kUj;Jtk; kw;Wk; jd;te;jphpFoe;ij thflj;jpy; 
Fwpg;gplg;gl;Ls;ssJ. 
 
,e;Neha; 3 khjk; Kjy; 12 taJ tiu tuf;$baJ. ghy; kl;LNk Fbf;Fk; 
gUtk>; ghYk;> NrhWk; cz;Zk; gUtk;> NrhW kl;;LNk cz;Zk; gUtk; Mfpa 
Kd;W gUtq;fspYk; khe;jk; Vw;gLk; vd gps;isg;gpzpkUj;Jtj;jpy; 
Fwpg;gplg;gl;Ls;sJ. 
 
Neha; tUk; top 
  ePh;epiyfspy; gOj;J> cjph;e;j rUFfs; tpOe;J mOfpapUf;Fk; ePiuf; 
Fbj;jy;. 
 vUikg;ghy;> Gspj;jvUikNkhh;> vUik nea;. thiog;gok;> khk;gok;> 
Njq;fha;> ,sePh;> fliy> nty;yk;> fhl;;Lj; Jtiu> nkhr;irf;nfhl;il> 
Gspaq;nfhl;il> gUg;G cUz;il> khtpdhy; nra;ag;gl;l nghUl;fs;> mjpurk;> 
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thAg;nghUl;fs;> NrhW ,itfis mjpfkhf cz;zy; Kjypa 
fhuzq;fshy; khe;j Neha; cz;lhFk; vd Foe;ij kUj;Jtk; Fwpg;gpLfpwJ. 
 ke;jg; nghUshfpa vUikg;ghy;> nea;> thiog;gok;> khk;gok;> fliy> 
nty;yk;> khkprk;> gUg;G;> cSit kPd;> tuhy; kPd;> nfz;il Mfpatw;iw 
Foe;ijfs;cz;Zk;NghJ khe;jNeha; cz;lhFk; vd jd;te;jphp Foe;ij 
thflk; $WfpwJ. 
 ghfw;fha;> Riu> cSe;J> Cd;> nghpa cSitkPd;> thiskPd;> gd;wp,iwr;rp> 
tpuhy;kPd;> nfz;ilkPd; Mfpa Mfhj nghUl;fs; cz;gjhYk;> khe;jNeha; 
cz;lhFk; vd gps;isg;gpzp  kUj;Jtk; Fwpg;gpLfpwJ. 
 NkYk; NrhW kl;LNk cz;Zk; Foe;ijapd; czT Fw;wj;jpdhYk; cztpd; 
NtWghl;lhYk; khe;jk; Vw;gLk;. 
 Foe;ijapd;  Ja;ikaw;w  jd;ik> rhpahd Neuj;jpy;rhg;gplhJ Neue;jtwp 
rhg;gply;> Rj;jkw;w czTg; nghUl;fisr;rhg;gply;> clk;gpy; Nghjpa 
Cl;lr;rj;J ,y;yhj epiy Mfpa fhuz;q;fspdhYk; ,g;gUtj;jpy; ,;e;Neha; 
tUk;. 
 cztpdhy; kl;Lkpd;wp nraypd; NtWghl;lhYk; khe;j Neha; Foe;ijiaj; 
jhf;Fk;. tWik> grp> Jauk;> kdf;ftiy> gak;> Nfhgk;>,r;ir Nghd;w 
czh;Tfshy; Foe;ijahdJ jhf;FWk; NghJ czTr;nrhpf;Fk; jd;ikapy; 
khWghL epfo;e;J khe;jk; cz;lhfpwJ vd gps;isg;gpzp kUj;Jtk; $WfpwJ. 
 Nkjpg;ghy;> nea;>fjypg;gok;> Njq;fha;>,sePh;> nty;yk;> Gspj;j Nkhu;> khkprk;> 
fdpfs;>cSe;J> nkhr;ir> Gspaq;nfhl;il> cSit> nfz;ilkPd;> ghfy;> 
Riu Kjyhd thAg; gz;lq;fis ghy; nfhLf;Fk;  khju;fs; kpFjpahf 
cz;lhy; my;yJ Foe;ijfs; mjpfkhf cz;lhy; khe;j Neha; cz;lhFk;  
vd Mtp mspf;Fk; mKj Kiw RUf;fj;jpy; Fwpg;gplg;gl;Ls;sJ 
 
Neha; tiffs; 
Foe;ij kUj;Jtj;jpy; khe;j Neha; 21 tiffshfg; gpupf;fg;gl;Ls;sJ  
1. tsp khe;jk; 
2. moy; khe;jk; 
3. Iak; khe;jk;  
4. tply; khe;jk; 
5. Nghh; khe;jk; 
6. thiy khe;jk; 
7. Ruk; khe;jk; 
8. ePh; khe;jk; 
9. nrhpah khe;jk; 
10. fl;L khe;jk; 
11. ghy; khe;jk; 
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12. vhp khe;jk; 
13. Jis khe;jk; 
14. Jiy khe;jk; 
15. fzk; khe;jk; 
16. typg;G(,Og;G) khe;jk; 
17. Rop khe;jk; 
18. Kf;F khe;jk; 
19. re;ep khe;jk; 
20. Cjy; khe;jk; 
21. tPf;fk; khe;jk;  
 
,J jtpu NkYk; 10tif Fwpg;gplg;gl;Ls;sd. 
1. cg;gy; khe;jk; 
2. the;jp khe;jk; 
3. twl;rp khe;jk; 
4. jpl;L khe;jk; 
5. cis khe;jk; 
6. mf;fuk; khe;jk; 
7. Nga; khe;jk; 
8. ePh;fzk; khe;jk; 
9. Njhlk; khe;jk; 
10.fUg;gk; khe;jk;  
vdTk; kw;nwhU tifg;ghl;bd; gb> vz;tif khe;jk; fPo;f;fz;l tiffs; 
nfhLf;fg;gl;Ls;sJ. 
 
1. nghJ khe;jk; 
2. nrhpah khe;jk; 
3. jiy khe;jk; 
4. Nghh; khe;jk; 
5. fl;L khe;jk; 
6. tpl khe;jk; 
7. ePu; khe;jk; 
8. Rop khe;jk; 
jd;te;jphp ghythflj;jpy; khe;jNeha; 21 tiffshf tifg;gLj;jg;gl;Ls;sJ 
1. moy; khe;jk; 
2. Cjy; khe;jk; 
3. vhp khe;jk; 
4. Iak; khe;jk; 
5. fzk; khe;jk; 
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6. re;ep khe;jk; 
7. Ruk; khe;jk; 
8. Rhp khe;jk; 
9. nrhpahik khe;jk; 
10. jiy khe;jk; 
11. Jiy khe;jk; 
12. ePu; khe;jk; 
13. ghy; khe;jk; 
14. Nghu; khe;jk; 
15. Kf;F khe;jk; 
16. typg;G khe;jk; 
17. tsp khe;jk; 
18. thiy khe;jk; 
19. tplk; khe;jk; 
20. tPf;fk; khe;jk; 
 
mDgt itj;jpa Njtufrpaj;jpy; 8 tiffs;;;: 
1. nrhpah khe;jk; 
2. gPh; khe;jk; 
3. Ru khe;jk; 
4. tp~ khe;jk; 
5. Rop khe;jk; 
6. CJ khe;jk; 
7. ePh; khe;jk; 
8. jiy khe;jk; 
kjiy Neha; Ehypy; khe;jk ;13 tiffshfg; gphpf;fg;gl;Ls;sJ. 
(Fk;g Kdp ghythflk;) 
 
“Njhd;wpa thjgpj;jk;nrhy;ypa rpnyw;g khe;jk; 
Cd;wpaajLf;F khe;jk; tpr khe;jk; Nghh; khe;jkjhd; 
fd;wpaghy; khe;jk; td;fg nghJ khe;jk; gpd; 
te;jpLk;tpidahk; rd;dptyp rh;j;jp gjp%d;whjhNk” 
 
mitahtd: 
1. thj khe;jk; 
2. gpj;j khe;jk; 
3. rpNyw;gd khe;jk; 
4. eLf;F khe;jk; 
5. tp~ khe;jk; 
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6. Nghh; khe;jk; 
7. ghy; khe;jk; 
8. td;fg khe;jk; 
9. nghJ khe;jk; 
10. tpid khe;jk; 
11. rd;dp khe;jk; 
12. typ khe;jk; 
13. rhj;jp khe;jk; 
 
gps;isg;gpzp kUj;Jtk; : 
Definition: 
Indigested food in the stomach causes abdominal distension and manifests as 
Mantha Noi with vomiting and diarrhoea. 
“ke;jkJ tuyhW nrhy;yf; NfsPu; 
khjNuhL ghyfU kUe;Je; jPdp 
Nru;e;jnjhU ghy;jdpNy tpre;jhd; nfhz;L 
rpWtUf;F cjuj;jpy; ke;jk; gw;wp 
Cu;j;nj*e;j jpiuapdhy; tpuzq;nfhz;L 
cs; tpuzk; gy NehT cwt jhfp 
rhu;e;j kyk; rpf;fpajpy; Njhr Kz;lha; 
jhnd*k;Gk; khe;jtif rhw;W NtNd” 
     --gps;is gpzp kUj;Jtk; 
 
The above verse states that Mantham occurs in children due the diet taken by the 
mother and the child, which causes indigestion and other related diseases.  According to the 
Pillai Pini Maruthuvantext, Mantham occurs from the age of 3 months to 12 years in 
children particularly while child having breast milk (Exclusive Breast Feeding), then   
weaning  period during  which   both milk and solid foods  were given and later  stage  
where the child given solid feeds (late weaning period). 
 
During the period of exclusive breast feeding if the mother takes food which is not 
easily digestable in large amounts.The child becomes affected by Mantha Noi due to the 
intake of mother‟s devitalized milk. The psychological feelings of the mother also affects 
the quality of milk given to the child. 
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During the weaning period, due to the diet taken by both the mother and the child 
causes Mantha Noi. The psychosomatic feelings of mother like hunger, poverty, anger, fear, 
desire affects the efficacy of the milk fed to the child in this period. 
During the late weaning period, the disease occurs mainly due to the improper food 
habits of children like taking not easily digestable foods, taking cleanless foods, taking 
irregular meal and taking imbalanced diet. Malnourished children are also affected by 
Mantham. 
 
gps;isg;gpzp kUj;Jtk; ghfk; 2y; khe;jj;jpd; tiffs;- 53 
In Pillai Pini Maruthuvam part 2 (Types 43) 
1. Adai Mantham 
2. Atcha  Akkara Mantham 
3. Azhal Mantham 
4. Allu Mantham 
5. Eluppu Mantham 
6. Uppal Mantham 
7. Uppu Mantham 
8. Ulai Mnatham 
9. Oothu Mantham 
10. Eri Mantham 
11. Iya Mantham 
12. Kattu Mantham 
13. Kana Mantham 
14. Karppa Mantham 
15. Kanai Mantham 
16. Kal Mantham 
17. Kazhi Mantham 
18. Sakthi Mantham 
19. Sanni Mantham 
20. Sanni Bhatha Mantham 
21. Sura Mantham 
22. Suzhi Mantham 
23. Seriya Mantham 
24. Thalai Mantham 
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25. Thittu Mantham 
26. Neer kana Mantham 
27. Thulai Mantham 
28. Neer Mantham 
29. Pal Mantham 
30. Pul Mantham 
31. Bethi Mantham 
32. Pei Mantham 
33. Por Mantham 
34. Maladi Mantham 
35. Mukku Mantham 
36. Valippu Mantham 
37. Vali Mantham 
38. Varatchi Mantham 
39. Vanthi Mantham 
40. Val Mantham 
41. Vida Mantham 
42. Thoda Mantham  
43. Veekka Manthamare described. 
43 tif khe;jq;fs;FwpFzq;fSld; fhzg;gLfpd;wd. 
kPjKs;s10 khe;jq;fs;ngaustpy; kl;Lk; tifg;gLj;jg;gl;Ls;sJ. 
 
Foe;ij kUj;Jtj;jpy; khe;jj;jpd; nghJ FwpFzq;fs;: 
 Foe;ijapd; clk;G Nrhu;e;J ,Uj;jy; 
 clk;G Nehjy; 
 kpFjpahd tpau;it cz;lhjy; 
 RWRWg;ghf,y;yhky; fz;tpop rpte;jpUj;jy; 
 fz;fs; Fop tpOe;J fhzy; 
 Kfk; ntSj;J xU tif kq;fpa xsp fhzy; 
 Fuy;jsu;e;J tha;cyu;e;Jfhzy; 
 Mbf;fb the;jp Vw;gly; 
 Grp,d;ikfhzy; 
 rPjKk; kyKkhfTk;> nfl;LNghd ghy; NghTyk;> jz;zPu; NghyTk; gy 
epwkhf Ngjpahjy; 
 if fhy;fs; #L ,y;yhky; Fspu;e;J fhzy;  
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fl;L khe;jf; FwpFzk; 
“jhahh; Kiyapy; tha;itj;Jr; 
rw;Nw Az;Zk; jpifj;jpUf;Fk; 
Xah jOif rpw;wpUky; 
cs;Ns RuK kpfTz;lhk; 
Nrah kyKQ; ryq;fl;br; 
rpf;fg; gz;Zk; grpapy;iy 
khah krf;F kpJfl;L 
khe;j nkd;W tFj;jdNu” 
    -ghythflk; 
 
FwpFzk; 
1. kyk; ryk; fl;LgLk; 
2. rw;Nw ghYz;Zk; 
3. grpapd;ik  
4. Ruk; 
5. nfhl;lhtp 
6. rpw;wpUky; 
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 Kf;Fw;w NtWghL 
 
czT Ntw;Wik 
 
Kf;Fw;w khWghL 
 
thA NfL miljy;(cjhdd; ghjpg;G) 
 
mghdd; ghjpg;G 
 
rkhdd; ghjpg;G 
 
 
jPf;Fw;w ghjpg;G 
(mdw;gpj;jk; ghjpg;G) 
 
 
czT nrhpahik 
 
 
khe;jk; 
 
Kf;Fw;w epiyfs;: 
i. Vali:  
Site of vadham in body  : thjk; thOkplk ; 
Abaanan, faces  idakalai, below the umblical region, spermatic cord, pelvic bones, skin, 
nerve plexus, joints, hair follicle, muscle, alimentary tract, bones, ear and thighs. 
NkYk;: 
 “mwpe;jpLk; thj klq;F kyj;jpdpy;”-jpU%yh; 
 “ehnkd;w thjj;Jf; fpUg;gplnk Nfsha; 
 ehgpf;Ff; fPnod;W etpy yhFk;"-A+fp Kdptu;. 
vd;gjhy;kyKk;> ehgpf;F fPoplKk;thjkpUf;Fkplq;fs;vd nfhs;syhk;   
rpj;jkUj;Jthq;fRUf;fk;(g.vz;.139) 
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Vadham consists of 10 types  
1. Praanan: (Uyirkaal)  
This controls knowledge, mind and five sense organs, which are useful for breathing 
and digestion.   
 
2. Abaaban: (Keezh nokkung kaal)  
This is responsible for all down ward movement such as passing urine, stools, 
semen, and menstrual flow. Abaanan vayu is affected in Kattu mantham due to constipation 
 
3. Samaanan: (Nadukkaal)  
This aids in proper digestion and controls other vayus. In Kattu mantham, this vayu 
is altered leading to poor appetite and cannot control the other vayus. 
 
4. Viyaanan: (Paravukaal)  
This is responsible for all movements of all parts of the body and distribution of 
saaram. This vayu is affected in Kattu mantham because of decreased activity due to 
symptoms like constipation. 
 
5. Uthaanan: (Mel Nokkung kaal)  
Responsible for all upward movementssuch as vomiting and nausea.It distributes the 
saaram equally to all tissues.It is affected in Kattu mantham because unequal distribution of 
saaram and presence of cough 
6.Naagan:  
Responsible for opening and closure of eye lids  
 
7. Koorman:  
Responsible for vision and yawning. .  
8. Kirukaran:  
This is responsible for salivation, nasal secretion, sneeze, cough and maintains the 
appetite. In Kattu mantham, this vayu is affected due to presence of cough and poor 
appetite. 
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9. Devathatthan:  
This is responsible for tiredness (Lazziness), anger and emotional expression.  This 
vayu is deranged in Kattu mantham because some patient had tiredness.  
 
10. Dhananjeyan:  
It produces swelling of the body after death. It escapes on the third day after death 
bursting out of the cranium.  
rpj;j kUj;Jthq;f RUf;fk;(g.vz;.142 - 149) 
 
ii. Azhal:  
Sites of pitham in body:  
Pinkalai, praanavayu, urinary bladder, moolakkini, heart, head, umblical region, stomach, 
sweat, saliva, blood, saaram, eyes and skin. 
“gpupe;jpLk;  gpj;jk; Nguhk; ryj;jpdpy;” -  jpU%yh; 
“Nghnkd;wgpj;jj;Jf; fpUg;gplNkNfsha; 
Nguhdfz;lj;jpd; fPNo jhFk;”-A+fpKdptu; 
$wpapUg;gjdhy; rpWePUk;> fz;lj;jpd;fPoplKk; gpj;jk; ,Ug;gplkhFk;. 
rpj;j kUj;Jthq;f RUf;fk;(g.vz;.153) 
 
Pitham consists of 5 types  
1. Anal pitham:  
It promotes appetite and helps in digestion. In Kattu mantham, it as affected due to 
presence of poor appetite.  
 
2. Ranjagam:  
It gives colour to the blood. In Kattu mantham, some children are anaemic.  
 
3. Saadhagam:  
It is important for day today activities with the help of mind and brain.  
 
4. Praasagam:  
It gives complexion to skin.   
 
5. Aalosagam: 
It brightens eyes and responsible for clear vision. 
-rpj;j kUj;Jthq;f RUf;fk;(g.vz;.155-157) 
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iii. Iyam:  
Sites of Kabam in body:  
 
Kabam (or) kapham is located in sammanavayu suzhumunai, sperm, head, tongue, 
uvula, fat, bone marrow, blood, nose, chest, nerve, bone, brain, large intestine, eyes, and 
joints and also present in throat, stomach and pancreas.  
-rpj;j kUj;Jthq;f RUf;fk; (g.vz;.158) 
Kabam consists of five types  
1. Avalambagam:  
It lies in the lungs. It controls the heart and other four kabams.  
In Kattu mantham, it is dearranged due to presence ofcough. 
 
2. Kilethagam:  
It lies in the stomach and gives moisture to food material and also helps for 
digestion. In this disease, it is affected because of  thepoor appetite present in children.  
 
3. Pothagam:  
It lies in tongue and responsible for taste sensation.  
 
 
4. Tharpagam:  
It is present in the head and responsible for coolness of both eyes.  
 
5. Santheegam:  
It is present in joints. Responsible for lubrication and free movements of joints.  
- rpj;j kUj;Jthq;f RUf;fk;(g.vz;.161 - 163) 
PINIYARI MURAIMAI: (DIAGNOSIS) 
 
Piniyari muraimai is a method of diagnosing a disease. The way of diagnosis is very 
important to the physician who deal the disease, because of that only he or she can pont out 
the cause of disease. 
,jidNa jpUts;Stu; jpUf;Fwspy; gpd;tUkhW $Wfpwhu; 
“Neha;ehb Neha;Kj dhbaJ jzpf;Fk; 
 tha;ehb tha;g;gr;nray;”   – jpUf;Fws;  
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Siddha system has a very unique method for diagnosis. This is based upon three 
principles.  
1. Poriyaal arithal (Inspection)  
2. Pulanaal arithal (Palpation)  
3. Vinaathal (Interrogation)  
 
I. Poriyaal arithal:  
Porigal means the five sense organs. These are eyes, ears, nose, tongue and skin. 
Poriyaal arithal is examining the five sense orgn of the patient by the five sense organ of the 
physician.  
          In kattu mantham, 
Mei (skin)   -  Normal  
Vaai (Tongue)  - Normal 
Kann (Eye)    -  Normal 
Mookku (Nose)  -  Normal 
Sevi (Ear)   -  Normal  
 
II. Pulanaal arithal:  
Pulan means sense of perception from the five sense ongans.That means 
understanding by the sense objects.  
 
In Kattu mantham,  
Ooru (sensation) -  Normal 
Oosai (sound)   -  Normal 
Oli (vision)   -  Normal  
Suvai (Taste)  -  Normal 
Naatram (smell)  -  Normal 
III. Vinaathal:  
Vinaathal means the physician should know about the patients name, age, 
occupation, family history, socio-economic status, diet and habits, complaints, relevant to 
disease in his family by asking questions. 
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Ezhu udar kattugal and Ennvagai thervugal also used for diagnosing a disease in 
Siddha system 
 
Ezhu udar kattugal:  
1. Saaram  
2. Senneer  
3. Oonn  
4. Kozhuppu  
5. Enbu  
6. Moolai  
7. Sukkilam/suronitham  
 
When the seven udar kattugal increase or decrease from the normal level, the normal 
functions of the body will be affected. 
 
In Kattu mantham. 
 
a. Saaram   : Deranged due to poor appetite causing tiredness. 
b. Senneer   : Deranged in some patient with nutritional anaemia. 
c. Oonn   :  Normal 
d. Kozhuppu  : Normal 
e. Enbu   : Normal 
f. Moolai   :  Normal.  
g. Sukkilam/ Suronitham :  Normal  
 
The diagnostic value of Enn Vagai thervugal is specific to Siddha system of medicine  
Enn vagai thervugal are:  
 
1. Naadi (Uyir thathu)  
2. Sparisam (Touch feel sensation)  
3. Naa (Tongue)  
4. Niram (Colour of the skin)  
5. Mozhi (Quality and character of speech)  
6. Vizhi (Eye)  
7. Malam (Stools)  
8. Moothiram (Urine)  
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Naadi (Uyir thathu) : 
Envagai thervugal is the basic diagnostic principles and the uniqueness of the siddha system 
of medicine. The following lines are said about this. 
“nka;f;Fwp epwe;njhdp tpop 
ehtpUkyk; iff;Fwp” 
             -rpj;j kUj;Jthq;f RUf;fk5;(g.vz;.483) 
  
Otherwise known as uyir thathu, is the principle method for diagnosis in siddha 
system. The naadi indicates the status of the body thathus and whether the body is normal or 
abnormal. It is responsible for existence of life in the physical body. It is said in literatures 
as 
“clypy; capu;jhpj;jpUg;gjw;F fhuzkhd rf;jp vJNth mJNt “jhJ 
my;yJ ehb” vdg;gLk;. 
“ehbg;guprk; ehepwk; nkhoptpop 
kyk;%j;jpukpit kUj;Jt uhAjk;” 
- Neha; ehly;Neha; Kjdhly6;(g.vz;. 270) 
In childrens the naadi nadai is not clearly seen. This is indicated by following lines,  
 
“nfhz;blNt faNuhfp fhrNuhfp  
Fwpg;ghfr; rpw;wpd;gk; nra;j Ngh;fs;  
mz;blNt jhpj;jpuHfs; tpUj;jH ghyh; 
md;ghfj; jz;zPhpy; %o;fpNdhHfs;  
nfhz;blNt ,th;fsJ cWg;gpd; jhJ  
$wNt KbahJ vth;f;Ff; fpl;Lk;” 
- Neha;ehly; Neha; Kjdhly; (g.vz;:171). 
 
b) Sparisam: (Touch feel sensation)  
Identify the heat or coldness of the body, pain and skin nature (soft or hard)  
In kattu mantham,  
 It may be hot due to fever.  
 It may be cold due to sweating.  
c)  Naa: (Tongue)  
It is noted for colour of the tongue local lesion (ulceration, redness), coating deposition of 
tongue and dryness of the tongue.  
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d)  Niram: (Colour of skin)  
Colour of skin, conjunctiva, teeth, tongue, nail bed and hair are noted In Kattu mantham,  
 Conjunctiva, nail bed may be pale due to nutritional anaemia 
e) Mozhi : (Quality and character of speech) 
Observation of speech and voice. This is said in Agasthiar vallathi as 
“thu;j;ijiag; ghu;” 
In Kattu mantham normal voice is present. 
 
f) Vizhi : (Eye)  
 
By this examination, colour of eye (redness, pallor) protrusion, tears, excreta of eye, 
disease of eyes are noted.  In Kattu mantham, the eyes of Some patients have pallor of 
lower eyelid due to nutritional anaemia.  
 
g) Malam : (stools)  
 
Consistency of stool,  smell, frequency of defeacation, constipation, quantity of stool 
are noted.  In Kattu mantham, patient have hard pellets like stools with decreased 
frequency. 
 
h) Moothiram : (Urine)  
 
Colour of urine (yellow, black, white copper colour, mixed colour. Then smell of 
urine (smell of fire, honey, sweet odours, fruity odour) frothy or not, frequency of urination 
and quantity of urine are noted.  
In Kattu mantham, there will be normal straw yellow colour of urine with decreased 
frequency of urine. 
 
Neer kuri and Nei kuri: 
This urine examination is unique in Siddha system of Medicine 
 
ePu;f;Fwp:- 
 
“mUe;J khwpujKk; mtpNuhjkjha; 
mfy; myu;jy; mfhyT+d; jtpu;e;jow; 
Fw;wstUe;jp cwq;fp itfiw 
Mbflffyrj; jhtpNa fhJ nga; 
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njhUK$u;j;jf; fiyf;Fl;gL ePupd; 
epwf;Fwp nea;f;Fwp epwkpj;jy; flNd” 
-Neha; ehly;Neha; Kjdhly;(g.vz;. 282) 
Collection of sample urine:- 
 
The patient must take well cooked food in the previous day. Food intake should be 
taken at correct time and avoid excessive intake. The urine is collected on the dawn of the 
next day in a pure glass container and closed immediately to prevent contamination. This 
specimen must be examined with in one and half hours from the collection.  
 
nea;f;Fwp:- 
 
“epwf;Fwpf; Fiuj;j epUkhz ePupw; 
rpwf;f ntz;nza;Nahu; rpWJsp eL tpLj; 
njd;Wwj; jpwe;njhyp Vfhjikj;jjp 
dpd;wjptiy Nghk; newp tpopawpTk;  
nrd;wJ GfYe;nra;jpia AzNu” 
- Neha; ehly;Neha; Kjdhly;(g.vz;. 298) 
 
A drop of gingelly oil is dropped on a wide glass vessel containing the urine to be 
tested which is kept under sunlight in a calm place. The derangement of three dhoshas can 
be diagnosed by the mode of spread of gingelly oil on the surface of urine.  
 
In Kattu mantham the results of nei kuri is snake  like oil floating on urine in some 
patients and ring like structure in some patients.  
 
MARUTHUVAM:  
 
The treatment in siddha medicine is aimed at keeping the Mukkutram in the state of 
equilibrium.  
i.e,  
 
 To bring down highly vitiated vatham to normal level  
 To bring down Vitiated pitham to normal level  
 To bring down Vitiated kabam due to vitiated vatham to normal level.  
 To strengthen the seven udar kattugal and maintains to normal level.  
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Keeping in mind the need for bringing out an effective therapy for Kattu mantham with the 
Chukku nei along with Chinni thuvalai as external therapy. 
 
Line of treatment:  
 
Siddha treatment is not only for to cure the disease but also teaches prevention and 
rejuvenation concepts.  Saint Thiruvalluvar says about the duty of a physician as follows 
 
“Neha;ehb Neha;Kj dhbaJ jzpf;Fk; 
tha;ehb tha;g;gr;nray;”           
– jpUf;Fws; 
”cw;whd sTk; gpzpasTq; fhyKq; 
fw;whd; fUjpr; nray;”  – jpUf;Fws;. 
 
From the above verse, it is essential to know the etiology, the nature of patients, 
severity of the illness, the seasons and the time of occurrence the disease must be observed 
clearly. 
 
Line of treatment is as follows : 
1. Kaappu (prevention)  
2. Neekkam (Treatment)  
3. Niraivu (Restoration)  
 
 
1. Kaappu: (Prevention)  
Prevention is the main aim of siddha system. Siddhars have described general 
preventive measures and special measures.  
 
Especially in Balavagadam, special preventive measures said for prevention of 
disease of the child. It starts from the conception and goes on the child grows up in intra 
uterine life and after delivery. ie diet of pregnant women, her habits, medicine to take in 
every month of pregnancy, her psychological conditions and surroundings. 
 
2. Neekkam: (Treatment)  
The aim of treatment is based on  
 To bring the three thodams into normal equilibrium state.  
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 To treat the patients according to the symptoms by the trial medicines Chukku nei as 
internal medicine and Chinni thuvalai as external therapy. 
 
Anupanam in Siddha system : 
“mDghdj;jhNy ato;jk; gypf;Fk;;> 
,dpjhd Rf;F fd;dy; ,;Q;rp – gpDKjfhy; 
NfhNkak; ghy; Kiyg;ghy; Nfhnea; Njd; ntw;wpiy ePu;;;:> 
Mopij ahuha;e;J nra;ayhk;” 
Njiuau; ntz;gh 
Siddha system considers anupanam as in important. It is otherwise known as 
“Thunai marunthu”, it can be translated as vehicle, adjuvant and supporting to drug  
therapy. Without anupanam, success in the treatment  is mostly not possible.  
 
Pathiyam in Siddha system : 
 During the course of treatment, the patients were advised to follow certain 
restrictions regarding diet and physical activities.  This type of medical advice termed as 
pathiyam. Importance of pathiyam is said by Siddhars Theraiyar as follows,  
 
“gj;jpaj;jpdhNy gyDz;lhFk; kUe;J 
gj;jpaq;fs; Nghdhy; gyd; NghFk; - gj;jpaj;jpy; 
gj;jpaNk ntw;wpjUk; gz;bju;f;F Mjypdhy; 
gj;jpaNk cj;jpnad;W ghu;”          - Njiuau; ntz;gh. 
The patient with Kattu mantham is advised to avoid spicy and hot food , 
contaminated water ,junk foods . 
 
3. Niraivu: (Restoration)  
 Reassurance of disease recovery was given to all patients.  
 All the patients are advised to prepare for lifestyle changes that provides a disease 
free life.  
 
Diet: 
Siddhars advise the diet regimens for Kattu mantham patients. They are explained 
below:  
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“fj;jphp Nga;Gly tiu apUghfy; gUq;fhsh fz;lfhhp  
mj;jpf; fha;fSk; tUf;ifkhgaw;iw fiuahy; gPHf;fUk; gpQ;RNth;  
nkha;j;j #uzq; fjypj; jz;Lfisg; G+Ksq;fp KUf;fUk;Gk;  
mj;jp G+rzpf; fhaUs;sp ts;spAq; fgj;NjhHf; fhzkhNk” 
gjhHj;j Fz rpe;jhkzp.  
 
“Ntis kzj;jf;fhsp nkd;rPij rf;futh;j;jp  
gPis triy Rf;F ngz;fzq;fs; - Ntisapy;  
nre;jspH fisf;fPiu nra;th; fgNjfH epjk;  
te;jspAzj;jhd; kfpo;e;J” 
- gjhHj;j Fz rpe;jhkzp.  
fha;fwpfs;:- 
 fj;jhp  
 Nga;Gly;  
 mtiu  
 fz;lq;fj;jphp  
 mj;jpf;fha;  
 gPHf;F  
 thioj;jz;L  
 KUq;if  
 ghfy;  
 G+rzp 
 Ks;sq;fp  
 
fPiufs;:- 
 kzj;jf;fhsp  
 rpWfz;gPis  
 triy  
 rpWfPiu  
 nghd;dhq;fd;dp  
 rf;futh;j;jp fPiu  
 Rf;F fPiu  Mfpaitfis cztpy; Nru;j;Jf;nfhs;sNtz;Lk;. 
 
 
 
3.2. MODERN ASPECTS 
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GASTROINTESTINAL  TRACT: 
The Gastrointestinal tract is the pathway were food passes from the mouth, through 
the esophagus, stomach, small and large intestine within where the nutrients are extracted 
for the needs of the body. The residue then passes to the rectum where it is evacuated. 
 
 
 
ANATOMY OF THE GASTROINTESTINAL TRACT: 
The Esophagus:  
The first part of the pathway of GIT is the esophagus, which  guides food from the 
mouth, where it is prepared by chewing down to the stomach where it is stored. 
 
The Stomach: 
The stomach is both a storage space, holding as much as a quart and a half of 
ingested food, and a secretory organ that produces the gastric acid necessary for digestion 
However, the stomach does not absorb food. When food enters the stomach from the 
esophagus it remains for a short period while it is mixed with gastric acid. The stomach then 
by involuntary muscle contractions (peristalsis) empties the food gradually into the 
duodenum, the first part of the small intestine. 
 
 
 
 
 
The small Intestine: 
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The small intestine consists of three parts: the duodenum, the jejunum and the ileum. 
In these three parts, certain digestive secretions are mixed with food, and the nutrients are 
absorbed into the blood stream 
 
I.The Duodenum: 
The duodenum treats the food it receives with bile from the liver and enzymes from 
the pancreas. It also adds liquid duodenal fluid that comes from the wall of the duodenum 
itself. The food, bile, enzymes and liquids brought together in the duodenum are then 
passed into the jejunum 
 
II.The Jejunum: 
The jejunum or second portion of the small intestine is approximately 10 feet long. 
It lies immediately behind the duodenum and continues the process of digestion, breaking 
down food into essential elements 
 
III.The Ileum: 
The ileum or third portion of the small intestine, like the jejunum, is about 10 feet 
long. It is here that a major part of the absorption of food products and liquids occurs. 
Waste products of the digestive process are passed from the small intestine or terminal 
ileum, into the large intestine, also known as the colon. 
 
Large Intestine (colon): 
 The colon moves waste products through about four feet by the continuing process 
of undulating motions or peristalsis, which is common to all parts of the gastrointestinal 
tract. The primary function of the colon is to store waste products of digestion prior to 
evacuation. The colon absorbs small amounts of water and electrolytes. 
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COMMON GASTROINTESTINAL TRACT DISORDER 
CONSTIPATION 
DEFINITION 
 Constipation refers to bowel movements that are infrequent or hard to pass. The 
stool is often hard and dry. Constipation is a symptom, not a disease. Most commonly 
constipation is thought of as infrequent bowel movements, usually less than 3 stools per 
week. Children may have other complaints as well  including 
 
 Straining with bowel movements 
 Excessive time needed to pass a bowel movement 
 Abdominal pain 
 Abdominal bloating 
 Pain with bowel movements secondary to straining 
 Hard or lumpy stool 
 Sensation of incomplete evacuation 
 
Newborns 
 First meconium stool usually within the first 36 hours of birth in normal newborns 
o 90% pass stool within 24 hours 
 This may happen later in preterm infants without underlying structural defects.  
 First week of life, normal newborn has 4 stools per day, with some variability 
o Breastfed infants can stool with each feeding or only once every 7 to 10 days 
o Formula feed infants tend to stool more regularly than breastfeed infants 
o Soy formulas known to cause harder stools 
o Protein Hydrolysate and Elemental formulas associated with looser stools  
 
Causes for Delayed passage of meconium 
 Intestinal Obstruction / Anatomical Malformation 
 Hirschsprung‟s Disease 
 Meconium Ileus 
 Functional Ileus (Prematurity, Sepsis) 
 Small left colon 
 Maternal Drugs 
 Hypothyroidism 
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Normal Frequency of Bowel Movements 
 
AGE 
MEAN OF BOWEL 
MOVEMENTS PER 
WEEK 
MEAN OF BOWEL 
MOVEMENTS PER 
DAY 
0-3 MONTHS 
BREASTFED 
5 TO 40 2.9 
0-3 MONTHS 
FORMULA FED 
5 TO 28 2.0 
6-12 MONTHS 5 TO 28 1.8 
1-3 YEARS 4 TO 21 1.4 
>3 YEARS 3 TO 14 1.0 
 
 
CONSTIPATION IN INFANTS AND TODDLERS: 
At least two of the following present for at least one month 
 Two or fewer defecations per week 
 At least one episode of incontinence after the acquisition of toileting skills 
 History of excessive stool retention 
 History of painful or hard bowel movements 
 Presence of a large fecal mass in the rectum 
 History of large-diameter stools that may obstruct the toilet 
 
Symptoms 
 Passing fewer than 3 stools per week 
 Hard or small stools 
 Abdominal distension 
 Abdominal and Rectal pain 
 Flatulence 
 Loss of appetite, nausea and vomiting 
 Lethargy  
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Chart no 3.2.1. Bristol Stool Chart 
 
 
Chronic Constipation 
 3% of the visits to general pediatrics 
 25% of the visits to pediatrics G.I. 
Epidemiology: 
The prevalence of childhood constipation in the general population ranged from 0.7% to 
29.6%. 
 
FUNCTIONAL AND ORGANIC TYPE OF CONSTIPATION 
Functional 
Over 95% of constipated children have functional constipation. Functional: 
persistent, difficult, infrequent, or seemingly incomplete defecation without evidence of 
underlying structural or metabolic defect. Most commonly due to with-holding after a 
painful bowel movement, most commonly at three age periods, at introduction of cereals 
and solid foods,at toilet training and at start of school days. 
 
Functional Constipation 
  Child has a painful bowel movement. When urge to have a bowel movement 
happens, the child consciously withholds stool by contracting their external anal sphincter 
and gluteal muscles. Eventually, the rectum habituates to the stimulus of the enlarging fecal 
mass, the urge to defecate subsides, and the retentive behaviour becomes almost second 
nature or subconscious can develop soiling (encopresis) 
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Organic 
 Accounts‟ for less than 5% of all constipation 
 Anatomic malformations 
 Metabolic causes 
 Neuropathic conditions 
 Intestinal nerve and muscle disorders 
 Drugs  
 Hypotonia 
 Miscellaneous 
 
CHRONIC CONSTIPATION: 
 Organic disorders are a major cause. A significant number of the children with 
chronic treatment-resistant constipation may have organic causes (slow colonic transit and 
outlet obstruction) and suggests new approaches to the management of children with 
chronic treatment-resistant constipation. Stool with holding presenting as a cause of non-
epileptic seizures. 
 
Chronic Constipation and food hypersensitivity 
 An increasing number of reports suggest a relationship between refractory chronic 
constipation and food allergy in children.  
 
History 
 Meconium passage 
 Frequency of bowel movement 
 Diet 
 School/Travel 
 Painful defecation 
 Family history 
 
Systemic Examination 
 Inspection 
o Abnormal appearance/position/patency of anus 
 Abdominal examination 
o Gross abdominal distension 
o Any abdominal mass 
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 Rectal examination 
o Anal sphincter tone 
o Presence of haemarrhoids 
o Any perianal irregularitiesincluding skin tag,anal fissures 
 
Evaluate of History 
 Meconium passage 
 Frequency of bowel movement 
 Diet 
 School/Travel 
 Painful defecation 
 Family history 
 
COMPLICATION 
 Haemarrhoid 
 Anal fissure 
 Fecal impaction 
 
INVESTIGATION 
 Thyroid function test 
 Plain abdominal X- rays are generally performed if bowel obstruction is suspected, 
may reveal extensive impacted fecal matter in the colon, and may confirm to rule 
out other causes of similar symptoms  
 Colonoscopy may br performed if an abnormality in the colon like a tumor is 
suspected. 
 Rarely ordered include Anorectal manometry, 
 Anal sphincter electromyography 
 Defecography 
 
TREATMENT 
The treatment of constipation should focus on the underlying cause if known. 
 Fiber Supplements 
 If Laxatives are used such as Milk of Magnesia or Polyethylene glycol are 
recommended as first line agents 
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 In case of  Chronic constipation, Polyethylene glycol appears superior to Lactulose. 
 Prokinetics may be used to increase Gastro intestinal motility 
 
MANAGEMENT 
 The goals of treating constipation in childhood are to produce soft, painless stools 
and to prevent the re accumulation of faeces. These outcome are achieved through a 
combination of  
 Education 
 Dietary modification 
 Maintenance 
 Behavioural Modification 
 
PREVENTION 
 Constipation is usually easier to prevent than to treat. Following the relief of 
constipation, maintainence with fluid intake and high fibre diet is recommended. 
 
PROGNOSIS 
 Complication that can arise from constipation include haemorrhoids, aanal fissured, 
rectal prolapse, and fecal impaction.straining to pass stool may lead to haemorrhoids. In 
later stage of age abdomen may become distended, hard and diffusely tender. 
 
DIET 
 Mild constipation 
o Increase fluid intake 
o Increase fiber intake 
Increase dietary fibers 
 Beetroot  
 Banana, Apple, Guava 
 Spinach 
 Green Leaf vegetables 
 Almond 
 Legumes 
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DIFFERENTIAL DIAGNOSIS 
A) Hirschsprung's Disease 
It is a congenital disease. Children with Hirschsprung's disease are missing the nerve 
cells (ganglion cells) within the wall of their colon or rectum. These cells are responsible for 
the normal wave-like motion of the bowel (peristalsis). When they are missing the stool 
stops and an obstruction occurs. The length of affected bowel varies. The most common 
transition point is in the upper rectum or the sigmoid colon. 
 
Symptoms 
 Vomiting and abdominal distention in newborn 
 Chronic constipation 
 More rarely diarrhea, fever, and distention (symptoms associated with enterocolitis – 
inflammation of the small intestine and colon). 
   
 B) Irritable bowel syndrome 
Irritable bowel syndrome (IBS) is a disturbance of bowel function that includes 
symptoms of abdominal pain or discomfort and altered bowel habit (change in frequency or 
consistency) – chronic or recurrent diarrhea, constipation, or both in alternation. IBS 
comprises a group of functional bowel disorders. 
 
Symptoms 
 
 Start with bowel movements that occur more or less often than usual 
 Start with stool that appears looser and more watery or harder and more lumpy than 
usual 
 Improve with a bowel movement symptoms must occur at least once per week for at 
least 2 months. 
COMPLICATION OF CONSTIPATION 
 Haemarrhoids 
 Rectal prolapse 
 Anal fissure 
 Fecal impaction 
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3.3. DRUG REVIEW 
THE REVIEW OF INGREDIENTS OF CHUKKU NEI 
INGREDIENTS:         
 Chukku (Zingiber officinale)     
 Citrarathai (Alpinia officinarum) 
 Vetrilai (piper betel) 
 Omum  (Trachyspermum ammi) 
 Murunga pattai (Moringa oleifera)                 - a mixture of 325 ml surasam 
 Vembu nei (Azadirachta indica)  - 325 ml 
 
1.  CHUKKU 
Botanical Name :   Zingiber officinale 
English Name  :   Dried Ginger  
 Family   :   Zingiberaceae 
Part used            :   Rhizome 
  
ORGANOLEPTIC CHARACTER 
Suvai :  Karppu 
Thanmai              :  Veppam 
Pirivu               :   Kaarppu 
 
  
nghJ Fzk;: 
R+iyke;jk; neQ;nrhpg;G NjhlNkg gk;;kio 
%yk; ,iug;gpUky; %f;FePh;-thyfg 
Njhlkjp rhue; njhlh;thj Fd;kePh;j; 
Njhlk;M kk;Nghf;FQ; Rf;F. 
     (mfj;jpah; Fzthflk;) 
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CHEMICAL CONSTITUENTS:   
 Camphene 
 Phellandrene 
 Zingiberine 
 Cineol and Borneol 
 Gingerol and shogoals 
 Diterpenes 
 Gingerglycolipids A,B,C 
 An Oleoresin-Gingerin 
 Resins and starch 
 β-Sesquiphellandrene 
 Gingerdiols, Gingerdiacetates. 
 
ACTIONS: 
 Carminative 
 Stomachic 
 Stimulant 
 
PHARMACOLOGICAL ACTION 
 Gastro protective 
 Antioxidant 
 Anti tussive 
 Antiemetic  
 Immunomodulatory 
 
RECENT RESEARCH 
A Review on Ginger – Gastroprotective Activity 
 Ginger and its constituent shows a vital role in ulcer prevention via increasing mucin 
secretion. Earlier finding have shown anti ulcer effects on ginger in experimental gastric 
model. Chief constituent of ginger such as gingerol, shogaols suppressed gastric contraction 
in situ and suppression by the shogoal was more intensive. 
 
 Journal of Pharmacognosy and Phytochemistry 2017, 6(3); 174-184 by Jyotsna 
Dhanik, Neelam Arya and Viveka Nand 
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Physiological and Pharmaceutical Effect of Ginger(Zingiber Officinale) As Avaluable 
Medicinal Plant 
 
 The active components of ginger is reported to stimulate digestion, absorption, 
relieves constipation and flatulence by increasing muscular activity in the digestive. 
 (European Journal of Experimental Biology, 2014, 4(1); 87-90 by Jalal Bayati 
Zadeh and Nasroallah Moradi Kor) 
 
2. OMUM 
 
Botanical Name :   Trachyspermum ammi 
English Name  :  The bishops weed 
Family   :  Apiaceae 
Parts used   :  Seeds 
 
ORGANOLEPTIC CHARACTER 
Suvai                :  Kaippu 
Thanma           :  Veppam 
Pirivu    :  Kaarppu 
   
nghJ Fzk; 
rPjRuq; fhrQ; nrhpahke; jk;nghUky; 
Ngjpapiur; ry;fLg;G Nguhkk; - XjpUky;  
gy;nyhLgy; %yk; gfkpitNeh nad;nrANkh? 
     nrhy;nyhLNghk; Xknkdr; nrhy;. 
(mfj;jpah; Fzthflk;) 
CHEMICAL CONSTITUENTS:    
 Thymol 
 P-cymene 
 Gamma terpinene 
 Beta pinene 
 Terpinene 
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ACTIONS: 
 Stomachic 
 Antispasmodic 
 Carminative 
 Antiseptic 
 Stimulant 
 Tonic 
PHARMACOLOGICAL ACTION 
 Gastro protective 
 Antioxidant 
 Anti tussive 
 Anti spasmodic 
 Diuretic 
 Anti tussive 
 Anti pyretic 
 
RECENT RESEARCH  
Gastroprotecrive activity of ethanolic extract of trachyspermmum ammi fruit  
 
 The oral administration of ethanolic extract of ammi fruit exhibits antiulcer in the 
experimental ulcer model. The probable mechanism for its activity may be due to Anti 
secretory and Cytoprotective property 
 (International journal of pharma and bio science v1(1)2010 by S.Ramaswamy and 
S.Sengottu velu) 
 
Gastroprotective activity of trachyspermum ammi against ethonolic induced gastric 
ulcer 
 Animals pretreated with hydroalcoholic extract of trachys.ammi at dose 250 mg/kg 
and 500mg/kg shows significant decreased in ulcer index and percentage ulcer production 
in all models.the results shows by reducing ulcerative lesion when compared to control 
group of animals. 
 
 (Journal of scientific research in pharmacy 2014, 3 (3)   96- 100 by Abdul Azeez, 
Mohammad Mansoor) 
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3. VETRILAI  
 
 Botanical Name    :  Piper betel  
English Name   :  Betal leaf 
Family              :  Piperaceae 
Part used          :   Leaf 
 
ORGANOLEPTIC CHARACTER 
 
Suvai           :  Viruvirupu, Kaarpu 
Thanmai  :  Veppam 
Pirivu        :  Kaarpu 
   
nghJ Fzk; 
Iak; mWq;fhz; mjd;fhuq; nfhz;lf;fhw; 
Igar; rapj;jpak;Nghk; ige;njhbNa!- nka;apd; 
fbapd; Fzk; Nghfq; fhuntw;wp iyf;Fg; 
gbAKh; Njhlkpijg; ghh;. 
(mfj;jpah; Fzthflk;) 
CHEMICAL CONSTITUENTS:    
 Piperol A 
 Piperol B 
 Methyl piper betlol 
 Eugenol 
 Essential oil 
 Starch  
 Ethyl acetate. 
 
ACTIONS: 
 Carminative 
 Stimulant 
 Astringent 
 Antiseptic 
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 Febrifuge 
 Stomachic 
 
PHARMACOLOGICAL ACTION 
 Anti histaminic, 
 Antioxidant, 
 Gastroprotective effect 
 
RECENT RESEARCH 
Influence of benzene extract of Piper betel on delayed in small intestine transit by 
chlorpromazine involving calcium innervation in mice 
 
 It is reported that calcium is involved in the initiation of contraction of smooth 
muscle. It increases small intestinal motility through L type channel. Chlorpromazone 
blocks the calcium channel and smooth muscle relaxes by attenuating intestinal motility. 
The present study was to evaluate the influence of benzene extract of piper betel on small 
intestinal motility. 
(International journey of current research and review www.ijcrr.com vol.01 issue 01) 
 
Evaluation Of Anti Ulcerogenic Potential of Piper Betel Leaves Extract as An 
Adjuvant Theraphy With Omeprazole Against Stress Ulcer In Rat 
( Pharmacologyonline 2:46-56 (2010)      katedeshmukh et al) 
 
Gastroprotectivity activity 
 The hot water piper betel leaves extract  study shows that it can protect against 
indomethacin induced gastric ulceration due to its anti oxidant and mucin protecting 
property 
  (Journal Of Pharmacognosy And Phytochemistry By Pradhan D;et al ,2013) 
 
4. CITRARATHTHAI 
Botanical Name :  Alpinia officinarum 
English Name  :  Galangal 
Family   :  Zingiberaceae 
Parts used   :   Rhizome  
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ORGANOLEPTIC CHARACTER 
Suvai                :  Kaippu 
Thanma           :  Veppam 
Pirivu    :  Karppu 
   
nghJ Fzk; : 
njhz;ilapw;fl; Lq;fgj;ij;j Jhuj; Juj;jptpLk; 
gz;ilr;rP jj;ijg; gwf;fbf;Fk; - nfz;iltpop 
kpd;Nd! fug;gidNt whf;Fk; grpnfhLf;;Fk; 
nrhd;Ndhk; muj;ijr; Rfk;. 
(mfj;jpah; Fzthflk;) 
CHEMICAL CONSTITUENTS:    
 Cineole 
 Beta caryophyllene 
 Methyl cinnammate 
 Alpha terpenol 
 Acetoxychavicol 
 Essential oil 
 Tannins,phenols,glycosides,carbohydrate, 
 Galangin,alpinin 
 Galangoisoflavanoid 
 
ACTIONS: 
 Expectorant 
 Febrifuge 
 Stomachic 
 
PHARMACOLOGICAL ACTIONS  
 Anti oxidant 
 Carminative 
 Anti pyretic 
 Anti spasmodic 
 Immuno modulator 
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RECENT RESEARCH  
Alpinia officinarum : phytochemistry and pleiotropism 
 
It has been reported that kaemjeride, kalangin and 7-1-phenyl hept 4ene one inhibit 
m-rna expression of tyrosinase and protein level of micropthalmia associated transcription 
factor.moreover 5 hydroxy 7-1-3-heptance has been noted to show anti emetic properties. 
The alcoholic effect of rhizome relieves stomach ache and treating cold. 
 (International Journal of Pharmaceutical And Phytopharmacological Research 2012, 
2(2); 122-125 By Arti Dixit, Ankur Rohilla) 
 
5. MURUNGAPATTAI 
 
Botanical Name :  Moringo oleifera  
English Name  :  Drum stick  
Family   : Moringaceae 
Part used  : Bark 
 
ORGANOLEPTIC CHARACTER 
Suvai   :   Kaippu, Thuvarpu, Inippu 
Thanmai             :   Thatpam  
Pirivu   :    Karppu 
 
nghJ Fzk; : 
KUq;ifNth;g; gl;ilf;F %L fgj;Njh 
nlhUQ;Fwhr; rd;dpfuk; XLk; - mUq;fdf> 
tl;ilg; nghUKiyaha;! tha;nthLtp lq;fSNkw; 
gl;ilf;Fg; NghNk gwe;J> 
 
CHEMICAL CONSTITUENTS: 
 Pterygospermin 
 Moringine 
 Moringinine 
 Beta sitosterol 
 Glycosides 
 
 
41 
  
 Tannin 
 Triterpenoids and steroids 
 Moringic acid 
 Niazinin A & B 
 Campesterol 
 Stigmasterol 
 Aminoacid 
 
ACTIONS: 
 Antispasmodic  
 Stimulant 
 Expectorant 
 Diuretic 
 
PHARMACOLOGICAL ACTION 
 Anti asthmatic 
 Antispasmodic 
 Antipyretic 
 Antioxidant 
 Diuretic 
 Gastroulcer protective 
 
RECENT RESEARCH  
Clinical efficacy of Moringa oleifera Lam.stems bark in Urinary Tract Infection 
 (International scholary research notices vol 2014, Article id 196843 by Santosh 
Kumar Maurya and Anil kumar Singh) 
 
Dietary effects of moringa oliefera leaf powder on growth gastro intestinal 
morphometry and blood liver metabolites in sprauge dawley rats  
 (Zvinorova Pl,et al. J Anim Physiol Anim Nutr(Berl) 2015 pubmed) 
 
 
 
6.VEMBU NEI 
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Botanical Name :   Azadirachta indica  
English Name  :   Margosa tree  
Family   :  Meliacea 
Part used  :  Seed  
  
ORGANOLEPTIC CHARACTER 
Suvai   :   Kaippu 
Thanmai             :   Veppam 
Pirivu   :    Karppu 
 
nghJ Fzk; 
thjk;Nghk; gpj;jkpFk; khwhf;fp ue;jpnahL 
NkhJfug; ghd;rpuq;F Kd;dprpTk;-XJlypd; 
ehg;g ZWRuK ehLrd;dp Ae;njhiyAk; 
Ntg;gnea; nad;nwhUf;fhy; tps;S. 
(mfj;jpah; Fzthflk;) 
CHEMICAL CONSTITUENTS:  
 Azadirachtin 
 Stigmasterol 
 Campesterol 
 Beta sitosterol 
 Omega 6,9 
 Triglycerides 
 Palmitic acid,stearic acid 
 Nimbin 
 
ACTIONS: 
 Stimulant 
 Antiseptic 
 Anthelmintic 
 Antiperiodic 
 Tonic 
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PHARMACOLOGICAL ACTION 
 Inhibit gastic hyper acidity and ulcer 
 
RECENT RESEARCH  
 
Neem oil, bark and leaf extracts have been therapaeutically used as folk medicine to 
control leprosy, respiratory disorder, intestinal helminthiasis, constipation and also a general 
health promoter. It posses a pharmacological activities are Antifungal, Anti bacterial, Anti 
malarial, Anti ulcer and Antioxidant. 
 
Neem oil nanoemulsions: characterization and antioxidant activity 
 (Rinaldi F, et al. J Enzyme inhib Med Chem 2017) 
 
REVIEW OF INGREDIENTS OF CHINNI THUVALAI- EXTERNAL MEDICINE 
Ingredients 
 Chinni ilai    (Acalypha fruticosa) 
 Notchi ilai    (Vitex negundo) 
 Seenthil ilai  (Tinospora cordifolia) 
 Vembu ilai    (Azadirachta indica) 
 
1. NEEM 
Botanical Name :  Azadirachta indica  
English Name  :  Margosa tree  
Family    : Meliaceae 
Part used  :  Leaf 
 
ORGANOLEPTIC CHARACTER 
Suvai   :  Kaippu 
Thanmai  :  Veppam 
Pirivu   :   Karppu 
 
 
nghJ Fzk; 
fpUkpFl;l khe;jq; nfLtplQ;R uq;fs; 
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nghUkpak R+hpifapd; Gz;fs; - xUkpf;f 
epk;gj; jpiyapUf;f ePLyfpy; ePq;fhky; 
fk;gj; jpiyapUf;ff; fhz;. 
 
CHEMICAL CONSTITUENTS:  
 Azadirachtin 
 Nimbin and deazyl nimbin 
 Salanin 
 Melianol 
 Nimbidin 
 Nimbinin 
 Azadirone 
 
ACTIONS: 
 Stimulant 
 Anthelmintic 
 
RECENT RESEARCH  
Therapaeutic Role of Azadirachta indica (Neem) And Their Active Constituents in 
Diseases Prevention and Treatment 
 
 Neem oil, bark and leaf extracts have been therapaeutically used as folk medicine to 
control leprosy, respiratory disorder, intestinal helminthiasis, constipation and also a general 
health promoter. It posses a pharmacological activities are Antifungal, Anti bacterial, Anti 
malarial, Anti ulcer and Antioxidant. The study based on animal model established that 
neem and its chief constituents play private role in anticancer management through the 
modulation of various molecular pathway including p53, Pten, Nf-B, P13 K/Akt, Bcl-2 and 
VEGF. It is considered as safe medicinal plants and modulates the numerous biological 
process without any adverse effect. 
 
 (Evidence Based Complementary and Alternative Medicine 2016, 2016> 
PMC4791507) 
 
2. NOTCHI  
 
Botanical Name          :   Vitex negundo 
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English Name  :  Five leaved chaste tree 
Family   :  Fabaeceae 
Part used  :  Leaf 
ORGANOLEPTIC CHARACTER 
Suvai   :   Kaippu,Thuvarpu, Kaarppu 
Thanmai  :   Veppam 
Pirivu   :    Karppu 
 
nghJ Fzk; 
 .....................................fu nehr;rpw; gl;ilaJ 
Js;Srd;dp thj kfw;Wk;;;;...... 
 
CHEMICAL CONSTITUENTS:   
 Negundoside 
 Terpenoids 
 Dimethoxy flavone 
 Vitexilactone 
 Vitexicarpin 
 Vitricine 
 Vitetrifolins 
 
ACTIONS 
 Alterative 
 Vermifuge 
 
RECENT RESEARCH  
Phytochemical Constituents and Pharmacological Activity of Vitex Negundo Linn 
  
It is large aromatic shrub.phytochemical investigation shows the predence of 
flavonoid,essential oil, ligands , glycoside and posses enormous pharmacological activity 
such as Antipyretic, Antioxidant, Anti tumour, Anti arthritic, Analgesic activity. 
  
(Journal of Chemical and Pharmaceutical Research,2016,8(2);800-807 by Suganthi 
N.And Sonal Dubey) 
 
3. .SEENTHIL 
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Botanical Name :  Tinospora cordifolia 
English Name  :  Heart leaved moon seed, Tinospora, Gulancha tinospora 
Family   :  Menispermaceae 
Part used   :  Leaves 
 
ORGANOLEPTIC CHARACTER 
Suvai                   :  Kaippu 
Thanmai              : Veppam 
Pirivu      :  Kaarppu 
 
nghJ Fzk; 
rPe;jpw; fpoq;fUe;jj; jPgdkhk; Nkftif 
Nghe;jTjp ug;gpj;jk; nghq;FRu - khe;jk; 
mjprhuk; nta;afzk; Mk;gyNeh NahNl 
fjptplKq; nfl;LtpLq; fhz 
 
CHEMICAL CONSTITUENTS:    
 Berberine  
 Palmatine 
 Phenylpropene disaccharides 
 Cordifolioside,  
 Asesqueterpene, 
 Choline tinosporicacid 
 Cordioside 
 Lactone 
 polysaccharides 
 
 
 
 
ACTIONS: 
 Alterative 
 Demulcent 
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 Antiperiodic 
 Stimulant 
 Stomachic 
 Tonic 
 Mild diuretic 
 
RECENT RESEARCH 
Chemistry and medicinal properties of Tinospora cordifolia (guduchi) 
 
The stem of Tinospora cordifoliais one of the constituents of several ayurvedic 
preparations used in general debility, dyspepsia, fever and urinary diseases. The stem is 
bitter, stomachic, diuretic, stimulates bile secretion, causes constipation, allays thirst, 
burning sensation, vomiting, enriches the blood and cure.s jaundice. The extract of its stem 
is useful in skin diseases. The root and stem of T. cordifolia are prescribed in combination 
with other drugs as an anti-dote to snake bite and scorpion stingDry barks of T. cordifolia 
has Anti-spasmodic, Antipyretic, Anti-allergic, Anti-inflammatory and Anti-leprotic 
properties. 
 
( Indian Journal of Pharmacology 2003; 35: 83-91 educationaforum) 
 
Tinospora cordifolia a phyto pharmacological revirew  
 The notable properties are Anti spasmodic, Anti diabetic, Anti inflammatory, Anti 
oxidant, Hepatoprotective and Immunomodulatory. 
 
( International Journal Of Pharmaceutical Science And Research 2017 By Garish 
Joshi And Rajandeep Kaur ) 
 
Enhance intestinal permeability of tinospora cordifolia extract through nano emulsion 
formulation in in vitro and ex- vivo studies 
 (Journal of nanopharmaceutics and drug delivery vol 2 num 3 sep 2014,pp,209 – 
218 (10) by Kumar Arun, Sanjay) 
  
 
4. CHINNI 
 
Botanical Name : Acalypha fruticosa 
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Telugu Name  : chinni 
Family   : Euphorbiaceae 
Part usd   : Leaf 
ORGANOLEPTIC CHARACTER 
 
Suvai                             :  Kaippu 
Thanmai    :  Veppam 
Pirivu    :   Karppu 
 
nghJ Fzk; 
fbtplKq; fhzhf; fbtplKk; khjh; 
,LtplKk; XLkpJ td;dp – nebatpopf; 
fd;dpifNa Nkfq; fzf;fha;r;ry; khe;jKk;NghQ; 
rpd;dp apiyf;Fj; njwpj;J 
 
 
CHEMICAL CONSTITUENTS:    
 Isocaryophyllene 
 Beta caryophyllene 
 Alpha humulene 
 Caryophyllene oxide 
 Trans phytol 
 
ACTIONS: 
 Alterative 
 Stomachic 
 
RECENT RESEARCH  
Bioactive and chemical characterization of acalypha fruticosa forssk. 
 Acalypha fruticosa is traditionally used as a cure for stomach ache, dyspepsia, 
rheumatism, dermatitis, and swellings of the body.the present study to endeavors to provide 
a phytochemical and biological evaluation of plant. By column chromatographic separation 
four compounds were isolated namely beta d glucopyranoside, Acalyphin, Apigenin, 
kaempferol 3-o-rutinoside were subjected to assay Anti inflammatory and Cytological 
activity. It promosing Anti inflammatory activity. 
  (Saudi Pharmaceutical Journal Vol 25, issue 1, Jan 2017 Pg 104-109 by Ghada 
Ahmed Fawzy) 
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Evaluation of Anti Epileptic Activity of Chloroform Extract of Acalypha Fruticosa In 
Mice 
( Pharmacognosy Research 2014 vol 6 issue 2 pg 108-112 by Sumalatha Govindu, 
Sreedevi Adikay ) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER IV 
 
4. MATERIALS AND METHODS 
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Kattu Mantham is one of   the common GIT disorder in children. In Ayothidoss 
pandithar Hospital NIS OPD 3-5% of cases are approaching Kuzhandhai Maruthuvam 
department daily with the Symptoms of Kattu Mantham. Hence, it was proposed to study 
about the disease. A protocol was prepared and submitted before IEC of  National 
Institute of Siddha. The IEC approval was obtained No: NIS/IEC/18-14/20-18-26-08-2014. 
The trial was registered in Clinical trial Registry of India with RegNo. CTRI/ 2016/04/ 
006818. After obtaining approval from  the committee, the clinical study on Kattu 
mantham(Constipation) in children with drug Chukku nei (internal) and Chinni thuvalai 
(external) are carried out as per the protocol. 
 
 Physicochemical analysis and pharmacological activity studies of Chukku nei 
(internal) were conducted in Noble Research Solutions, Chennai. 
 
After finishing the pharmacological Activity studies, 30 cases were selected from 
the OPD & IPD of Kuzhandhai Maruthuvam Department, National Institute of Siddha. 
Those meeting the inclusion and exclusion criteria they were treated with the trial drug with 
Chukku nei (internal) and Chinni thuvalai (external)and observed for prognosis clinicaly. 
 
PREPARATION OF CHUKKU NEI 
COLLECTION OF RAW DRUGS 
 
The required drugs were purchased from Ramaswamy Chettiyar country drug shop, 
kandha swamy kovil street Paris, Chennai. 
 
AUTHENTICATION 
 
Raw drugs were authenticated by the Medicinal Botanist in National Institute of 
Siddha, Chennai. The test drug Chukku nei was prepared at Gunapadam lab, National 
Institute of Siddha.Chennai-47 
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Preparation  
INGREDIENTS:         
 Chukku (Zingiber officinale)     
 Citrarathai (Alpinia officinarum) 
 Vetrilai (piper betel) 
 Omum  (Trachyspermum ammi) 
 Murunga pattai (Moringa oleifera)                 - a mixture of 325 ml surasam 
 Vembu nei (Azadirachta indica)  - 325 ml 
 
Ref: K.S.Murugesa mudhaliyar – Kuzhandhai Maruthuvam (Balavagadam) 5th Edition 
Indian System of Medicine and Homeopathy Department,Chennai-106 (2010) pg no 93 
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Ingredients of  Chukku nei (Internal) 
 
 
 
Fig no.4.1 Zingiber officinalis              Fig no.4.2  Trachyspermum ammi 
 
 
 
 
 
 
 
 
 
Fig no. 4.3. Piper betel                          Fig no. 4. 4 Alpinia officinarum 
 
 
 
 
 
 
 
 
 
Fig no.4.5 –Moringo oleifera              Fig no.4. 6 – Neem oil(Azadirachta indica)                   
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Fig no.4.7 chukku nei 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Purification Method:  
 Arathai  - Remove the outer  layer,cut into small pieces and dry it under shadow 
 Omum  - Soaked in limestone water and dry it 
 Murungapattai   - Clean and remove the outer layer 
 Chukku  - Double amount of limestone will be added with an amount of chukku 
fried for a period of 3 hours  after that  wash it,remove the outer layer and dry it 
 Vembu nei - It will be boiled with equal quantity of neem bark decoction 
 
 Method of preparing Chukkunei: 
All the ingredients except vembu nei were taken and grind with sufficient quantity of water 
and make it as surasam (325 ml) then vembu nei (325ml) will be mixed together and boiled 
and filtered it. 
 
Dosage : 5 ml once a day at morning 
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Drug Storage: 
Prepared medicine in oil form was stored in clean and dry air tight container. 
 
Dispensing:  
Prepared medicine of  5 ml oil given in separate dry air tight container. 
 
CHINNI  THUVALAI  (EXTERNAL) 
 
Ingredients 
 Chinni ilai    (Acalypha fruticosa) 
 Notchi ilai    (Vitex negundo) 
 Seenthil ilai  (Tinospora cordifolia) 
 Vembu ilai    (Azadirachta indica) 
 
 Ref: K.S.Murugesa mudhaliyar Kuzhandhai Maruthuvam (Balavagadam) 5
th
 Edition Indian 
System of Medicine and Homeopathy Department, Chennai-106 (2010) pg no 68 
 
Ingredients of Chinni thuvalai (External) 
 
 
Fig no.4.7- Azadirachta indica           Fig no.4. 8 - Vitex negundo 
 
Fig no.4. 9 – Tinospora cordifolia           Fig no.4.10 – Acalypha fruticosa 
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Preparation 
All the leaves were slightly heated and the juices were extracted separately then 
mixed all together. 
 
Application 
The prepared Chinni thuvalai  mixture has to be applied over both upper limbs and 
lower limbs for 3 days as thuvalai. 
Indication  
All types of Mantham cured 
 
PRECLINICAL  STUDIES 
 
4.1. Physicochemical Analysis 
The physicochemical analysis of the test drug Chukku nei was carried out as per 
WHO guidelines (Anonymous 1998). The test procedures were done in Noble research 
solutions, perungudi, Chennai. Since the form of the drug is in oil. 
 
Determination of specific gravity  
 
Fill the dry sp. gravity bottle with prepared samples in such a manner to prevent 
entrapment of air bubbles after removing the cap of side arm. Insert the stopper, immerse in 
water bath at 50
O
C and hold for 30 min.  Carefully wipe off any substance that has come out 
of the capillary opening. Remove the bottle from the bath, clean and dry it thoroughly. 
Remove the cap of the side and quickly weigh. Calculate the weight difference between the 
sample and reference standard. 
 
Determination of Weight per ml 
 Weight per ml was determined using the comparative weight calibration method, in 
which the weight of 1ml of the base of the formulation was calculated and then weight of 1 
ml of finished formulation were been calculated. The difference between weight variations 
of the base with respect to finished formulation calculated as an index of weight per ml. 
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Determination of Refractive Index 
Determination of RL was carried out using Refractometer. 
 
Determination of Viscosity value  
Viscosity determination were been carried out using Ostwald viscometers. 
Measurement of viscosity involves the determination of the time required for a given 
volume of liquid to flow through a capillary. The liquid is added to the viscometer, pulled 
into the upper reservoir by suction, and then allowed to drain by gravity back into the lower 
reservoir. The time that it takes for the liquid to pass between two etched marks, one above 
and one bellow the upper reservoir, is measured. 
 
Determination of pH 
 One gram of the testdrug was taken into a 100ml graduated cylinder containing 
about 50 ml of water. The cylinder was  shaken vigorously for two minutes and the 
suspension was allowed to settle for hour at 25ºC  to 27ºC, then 25 ml of the clear aqueous 
solution was transfered in to a 50 ml beaker and tested for pH using digital pH meter . 
 
Determination of Iodine value  
About 20 gm of test sample was transferred into Iodine flask. To which 10 ml of 
chloroform was added and warmed slightly and cooled for 10 minutes. Followed by this 
about 25 ml of Wiji‟s solution was added in the same flask and shaken well. The flask was 
allowed to stand for 30 mins and refrigerated for an hour.T About 10 ml of KI solution was 
added to this and titrated against 0.1 N Sodium thiosulphate solutions until the appearance 
of yellow colour. 1 ml of starch indicator was added and again titrated against the sodium 
thiosulphate solution from the burette. Disappearance of blue colour indicates end point. 
Repeat the above procedure without taking sample and note the corresponding reading for 
blank titration. 
 
Determination of saponification value  
About 2 gm of test sample was transferred into the round bottomed flask. To this 
about 20 ml of 0.5 N alcoholic KOH solutions was added to the round bottomed flask. 
Repeatthe same procedure with out taking the sample for blank titration . Reflux both 
sample and blank round bottomed flasks for 1 hour. After reflux, allow both the round 
bottomed flasks to cool. Titrate the samples using 0.5 N HCl with phenolphthalein 
indicator. The disappearance of pink indicates the end point.  
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Acid Value 
Accurately 5 g of test sample was weighed and transferred into a 250 mL conical 
flask. To this, a 50 mL of neutralized alcohol solution was added. This mixture was heated 
for 10 min by heating mantle. Afterwards, the solution was taken out after 10 min and 1 or 2 
drops of phenolphthalein indicator was added. This solution was titrated against KOH 
solution from the burette. The appearance of pink color indicated the end point. The volume 
of consumed KOH solution was determined and the titration of test sample was carried out 
in triplicate and the mean of the successive readings was used to calculate the acid-value of 
the respective sample by following expression. 
 
Acid value = Titter Value X 0.00561X 1000 / Wt of test sample (g) 
 
Peroxide value 
5 g of the substance being examined, accurately weighed, into a 250-ml glass-
stoppered conical flask, add 30 ml of a mixture of 3 volumes of glacial acetic acid and 2 
volumes of chloroform, swirl until dissolved and add 0.5ml volumes of saturated potassium 
iodide soluton. Allow to stand for exactly 1 minute, with occasional shaking, add 30 ml of 
water and titrate gradually, with continuous and vigorous shaking, with 0.01M sodium 
thiosulphate until the yellow colour almost disappears. Add 0.5 ml of starch solution and 
continue the titration, shaking vigorously until the blue colour just disappears (a ml). Repeat 
the operation omitting the substance being examined (b ml). The volume of 0.01M sodium 
thiosulphate in the blank determination must not exceed 0.1 ml. 
Calculation : Peroxide value = 10(a-b)/w 
 
TLC Analysis 
Test sample was subjected to thinlayer chromatography (TLC) as per conventional 
one dimensional ascending method using silica gel 60F254, 76 cm (Merck) were cut with 
ordinary household scissors. Plate markings were made with soft pencil.micro pipette were 
iused to plot the samplr for TLC applied sample volume 10-microliter by using pipette at 
adistance of 1 cm at 5 tracks. In the twin trough chamber with different solvent system 
Toulene : Ethyl Acetate:Acetic Acid (1.5:0.5)  after the run plates are dried and was 
observed using visible light short wave UV light 254 nm and long light wave UV light365 
nm. 
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High Performance Thin Layer Chromatography Analysis (HPTLC) 
 
 HPTLC method  is a sophisticated and automated selection technique derived from 
TLC. Pre coated HPTLC graded plates and auto sampler was used to achieve 
precision,sensitive,significant separation both qualitatively and quantitatively. HPTLC is a 
valuable quality assessment tool for the evaluation of botanical materials efficiently and 
cost effectively. It offers high degree of selectivity, sensitivity and rapidity combined with 
single step sample preparation. In addition it is a reliable method for the quantitation of 
nano grams level of samples. Thus this method can be conveniently adopted for routine 
quality control analysis. It provides chromatographic finger prints of phytochemicals which 
is suitable for confirming the identity purity of medicinal plant raw materials. 
  
Chromatogram development 
 
 It was carried out in CAMAG twin trough chambers. Sample elution was carried out 
according to the adsorption capability of the component to be analysed. After elution, 
platees were taken out of the chamber and dried. 
Scanning 
 
 Plates were scanned under UV at 366 nm. The data obtained from scanning were 
brought into integration through CAMAG software. Chromatographic finger print ewas 
developed for the detection of phytoconstituentsbpresent in each extract and Rf value were 
tabulated  
 
Flourescent analysis 
Fluorescence analysis in dried powder  
 
Sample CN was subjected to fluorescence analysis under visible light and UV – 
Light at 365 nm under closed circuit cabinet. Each fluorescence characteristic of the treated 
sample was observed underordinary light and then under UV light of wave lengths 365 nm. 
The drug was treated with acids viz., Conc. HCl, Conc. H2SO4, Conc. HNO3 and glacial 
acetic acid. The drug was treated with alkaline solutions viz., aqueous NaOH and ferric 
chloride. They were subjected to fluorescence analysis in visible light and in short UV- light 
(254 nm) and long UV- light (365 nm) 
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Fig no. 4.1.1 Visible light 
 
 
 
 
 
 
 
 
Fig no.4.1.2  Short UV light – 254 nm 
 
  
 
 
 
 
 
 
 
 
Fig no. 4.1.3  Long UV light– 365 nm 
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Test for Heavy metal Analysis 
 
Atomic Absorption Spectrometry (AAS) is a very common and reliable technique 
for detecting metals and metalloids in environmental samples. The total heavy metal content 
of the sample was performed by Atomic Absorption Spectrometry (AAS) Model AA 240 
Series. In order to determination the heavy metals such as mercury, arsenic, lead and 
cadmium concentrations in the test sample .Test sample digested with 1mol/L HCl for 
determination of arsenic and mercury.Similarly for the determination of lead and cadmium 
the sample were digested with 1mol/L ofHNO3. 
 
Sterlity test by pour plate method 
Methodology 
About 1ml of the test sample was inoculated in sterile petri dish to which about 15 mL of 
molten agar 45
o
C were added. Agar and sample were mixed thoroughly by tilting and 
swirling the dish. Agar was allowed to completely gel without disturbing it. (about 10 
minutes). Plates were then inverted and incubated at 37
o
 C for 24-48 hours. Grown colonies 
of organism was then counted and calculated for CFU.  
 
 
Fig no.4.1.4 Test sample with agar   Fig no.4.1.5  No growth colonies   
 
Test for specific pathogen 
Methodology 
0.5 ml of the test sample was directly inoculated in to the specific pathogen medium (EMB, 
DCC, Mannitol ,Cetrimide) by pour plate method. The plates were incubated at 37
o
C for 24 
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– 72 hr for observation. Presence of specific pathogen identified by their characteristic color 
with respect to pattern of colony formation in each differential media. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig no.4.1.6 Culture plate with e.coli and salmonella specific medium 
 
 
 
Fig no. 4.1.7 Culture plate with staphylococcus aureus specific medium 
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Fig no.4.1.8 Culture plate with pseudomonas aureus specific medium 
 
Test for Organochlorine pesticide, organophosphorous pesticide and pyrethroids 
About 10 g of test substance were extracted with 100 ml of acetone and followed 
byhomogenization for brief period. Further filtration was allowed and subsequent addition 
of acetone to the test mixture. Heating of test sample was performed using a rotary 
evaporator at a temperature not exceeding 40ºC until the solvent has almost completely 
evaporated. To the residue add a few milliliters of toluene R and heat again until the acetone 
is completely removed. Resultant residue will be dissolved using toluene and filtered 
through membrane filter. 
 
Aflotoxin Assay by TLC 
Standard aflatoxin was applied on to the surface to pre coated TLC plate in the 
volume of 2.5 µL, 5 µL, 7.5 µL and 10 µL. Similarly the test sample was placed and Allow 
the spots to dry and develop the chromatogram in an unsaturated chamber containing a 
solvent system consisting of a mixture of chloroform, acetone and isopropyl alcohol (85 : 
10 : 5) until the solvent front has moved not less than 15 cm from the origin. Remove the 
plate from the developing chamber, mark the solvent from and allow the plate to air-dry. 
Locate the spots on the plate by examination under UV light at 365 nm.  
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4.2. Phytochemical Analysis 
 
Sample preparation 
 Chukku nei (CN) was extracted with ethanol and the extracted was subjected to 
following analysis 
 
Test for alkaloids: 
Mayer's Test: To the test sample, 2ml of mayer's reagent was added, a dull white 
precipitate revealed the presence of alkaloids. 
 
Test for coumarins:  
To the test sample, 1 ml of 10% sodium hydroxide was added. The presence of 
coumarins is indicated by the formation of yellow color. 
 
Test for saponins:  
       To the test sample, 5 ml of water was added and the tube was shaken vigorously. 
Copious lather formation indicates the presence of Saponins. 
 
Test for tannins:  
       To the test sample, ferric chloride was added, formation of a dark blue or greenish 
black color showed the presence of tannins. 
 
Test for glycosides- Borntrager’s Test 
Test drug is hydrolysed with concentrated hydrochloric acid for 2 hours on a water 
bath, filtered and the hydrolysate is subjected to the following tests. To 2 ml of filtered 
hydrolysate, 3 ml of choloroform is added and shaken, choloroform layer is separated 
and 10% ammomia solution is added to it. Pink colour indicates presence of glycosides. 
 
Test for flavonoids: 
To the test sample about 5 ml of dilute ammonia solution were been added followed 
by addition of few drops of conc. Sulfuric acid. Appearance of yellow color indicates the 
presence of Flavonoids. 
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Test for phenols: 
Lead acetate test: To the test sample; 3 ml of 10% lead acetate solution was added.  A 
bulky white precipitate indicated the presence of phenolic compounds. 
 
Test for steroids: 
To the test sample , 2ml of chloroform was added with few drops of conc. Sulphuric 
acid (3ml), and shaken well. The upper layer in the test tube was turns into red and 
sulphuric acid layer showed yellow with green fluorescence. It showed the presence of 
steroids. 
 
Triterpenoids   
Liebermann–Burchard test: To the chloroform solution, few drops of acetic 
anhydride was added then mixed well. 1 ml concentrated sulphuric acid was added from the 
sides of the test tube, appearance of red ring indicates the presence of triterpenoids. 
 
Test for Cyanins 
A. Aanthocyanin: 
To the test sample, 1 ml of 2N sodium hydroxide was added and heated for 5 min at 
100 Cᵒ. Formation of bluish green colour indicates the presence of anthocyanin. 
 
Test for Carbohydrates - Benedict’s test 
To the test sample about 0.5 ml of Benedic‟s reagent is added. The mixture is heated 
on a boiling water bath for 2 minutes. A characteristic coloured precipitate indicates the 
presence of sugar. 
 
Proteins (Biuret Test) 
 To extracts 1% solution of copper sulphate was added followed by 5% solution of 
sodium hydroxide, formation of violet purple colour indicates the presence of proteins. 
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 .  
Fig no.4.2.1Test for Alakaloid       Fig no.4.2.2Test for Flavanoid 
 
  
Fig no.4.2.3Test for Glycosides   Fig no.4.2.4Test for Steroids 
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Fig no.4.2.5 Test for Coumarin   Fig no.4.2.6Test for Triterpenoids  
  
Fig no.4.2.7Test for Phenols   Fig no.4.2.7 Test for Tannin 
  
 
Fig no.4.2.8Test for protein         Fig no.4.2.9Test for Saponin 
  
Fig no. 4.2.10 Test for Carbohydrate  Fig no.4.2.11Test for Beta cyanin 
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4.3. Biochemical Analysis 
Biochemical Analysis of Chukku nei was done at the Biochemistry lab at National 
Institute of Siddha, Chennai by the method of Kolkate. 
 
Preparation of Extract: 
5ml of sample was taken in a 250ml clean beaker and added with 50ml of distilled 
water. Then it is boiled well for about 10 minutes. Then it is cooled and filtered in a 100ml 
volumetric flask and made up to 100ml with distilled water. This preparation is used for the 
qualitative analysis of acidic/basic radicals and biochemical constituents in it. 
 
Procedure: 
Test for Silicate 
A 2ml of the sample was shaken well with distilled water. 
 
Action of Heat: 
           A 2ml of the sample was taken in a dry test tube and heated gently at first and then 
strong. 
 
Ash Test: 
            A filter paper was soaked into a mixture of extract and dil. cobalt nitrate solution 
and introduced into the Bunsen flame and ignited 
 
4.3.1. Test for Acid Radicals 
Test for Sulphate: 
  2ml of the above prepared extract was taken in a test tube to this added 2ml of 4% dil 
ammonium oxalate solution 
 
 Test for chloride: 
2ml of the above prepared extracts was added with 2ml of dil.HCl is added until the 
effervescence ceases off. 
 
Test for Phosphate: 
2ml of the extract were treated with 2ml of dil.ammonium molybdate solution and 2ml of 
con.HNo3. 
 
 
 
 
68 
  
Test for carbonate: 
2ml of the extract was treated with 2ml of dil. magnesium sulphate solution. 
 
Test for Nitrate: 
1gm of the extract was heated with copper turning and concentrated H2So4 and viewed the 
test tube vertically down. 
 
4.3.2. Test for Basic radicals 
Test for lead: 
2ml of the extract was added with 2ml of dil.potassium iodine solution. 
 
Test for copper: 
One pinch (25mg) of extract was made into paste with con. HClin a watch glass and 
introduced into the non-luminuous part of the flame. 
 
Test for Aluminium: 
           To the 2ml of extract dil.sodium hydroxide was added in 5 drops to excess. 
 
Test for Iron:  
           a. To the 2ml of extract add 2ml of dil.ammonium solution  
           b. To the 2ml of extract 2ml of thiocyanate solution and 2ml of con HNo3 is added. 
 
Test for Zinc: 
To 2ml of the extract dil.sodium hydroxide solution was added in 5 drops to excess and dil. 
ammonium chloride were added.  
 
Test for Calcium: 
To 2ml of the extract was added with 2ml of 4% dil.ammonium oxalate solution 
 
 
Test for Magnesium: 
To 2ml of extract dil.sodium hydroxide solution was added in drops to excess. 
 
Test for Ammonium: 
To 2ml of extract 1 ml of Nessler's reagent and excess of dil.sodium hydroxide solution are 
added. 
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Test for Potassium: 
A pinch (25mg) of extract was treated of with 2ml of dil.sodium nitrite solution and then 
treated with 2ml of dil.cobalt nitrate in 30% dil.glacial acetic acid. 
 
 Test for Sodium: 
2 pinches (50mg) of the extract is made into paste by using HCl  and introduced into the 
blue flame of Bunsen burner. 
 
Test for Mercury: 
2ml of the extract was treated with 2ml of dil.sodium hydroxide solution. 
 
Test for Arsenic: 
2ml of the extract was treated with 2ml of dil.sodium hydroxide solution 
 
4.3.3 Miscellaneous 
Test for Starch: 
2ml of extract was treated with weak dil.Iodine solution. 
 
Test For Reducing Sugar: 
5ml of Benedict's qualitative solution was taken in a test tube and allowed to boil for 2 
minutes and added 8 to 10 drops of the extract and again boil it for 2 minutes. The colour 
changes are noted. 
 
Test for alkaloids: 
Mayer's Test: To the test sample, 2ml of mayer's reagent was added, a dull white precipitate 
revealed the presence of alkaloids. 
 
Test for tannic acid: 
To the 2 ml of extract was treated with 2 ml of dil.ferric chloride solution 
 
Test for Unsaturated Compound: 
To the 2ml of extract 2ml of dil.Potassium permanganate solution was added. 
 
Test for AminoAcid: 
2 drops of the extract was placed on a filter paper and dried well. 20ml of Burette reagent is 
added. 
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Test for Type of Compound: 
2ml of the extract was treated with 2 ml of dil.ferric chloride solution. 
 
4.4. Pharmacological Activity 
In-vitro Carminative Activity 
 
Project ID  :  NRS/AS/0087/01/2018 
Institute  :  National Institute of Siddha 
Sample Name  :  Chukku nei  
Sample ID   :  CN 
 
In-vitro Carminative activity acid-base titration Method 
 
In-vitro carminative activity of the chukka Nei was evaluated by modified method of 
Swapnil Sharma et al. About 10,20 and 40 ml of the CN were placed in conical flask fitted 
with air-tight nozzle, to this 100 ml of distill water was added. About 100 ml of NaOH 
{1M, previously standardized to oxalic acid} was poured into a plastic container fitted with 
aeration tubing system that was connected directly to the reaction vessel containing varying 
volume of CN. The flask was agitated manually for the next 45 mins and vigorously for 
another 30 mins and was allowed to stand for overnight. The carbon dioxide gas evolved 
from the reaction vessel was allowed to pass into a plastic container containing excess 
sodium hydroxide where it was absorbed and converted into equivalent amount of sodium 
carbonate. The resulting mixture consisting of excess sodium hydroxide and sodium 
carbonate was titrated with standard HCl using phenolphthalein as indicator to get first 
endpoint and in continuation to this the second endpoint was enumerated using methyl 
orange as indicator. The difference in milliliters between the first & second endpoints was 
used to calculate the carbon dioxide content per gram of sample. 
 
Vol. of titrant x molarity of std. acid x mol. Wt. of CO2 = mass of CO2 in gm 
Molarity of the Acid is 0.09184 M 
Mol. Wt. of CO2 is 44.01 g/mol 
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Triplicate 1 
Volume of Test Sample Difference in Titration value (ml) Mass of CO2 in gm 
10 1.7 6.87 
20 2.4 9.70 
40 4.8 19.40 
 
Triplicate 2 
Volume of Test Sample Difference in Titration value (ml) Mass of CO2 in gm 
10 1.4 5.65 
20 2.3 9.29 
40 5.0 20.20 
 
Triplicate 3 
Volume of Test Sample Difference in Titration value (ml) Mass of CO2 in gm 
10 2.0 8.08 
20 2.8 11.31 
40 4.4 17.78 
 
Fig no. 4.4.1 Reaction setup   Fig no. 4.4.2Evolvement of   
     Sample Chukku nei       carbon dioxide from the reaction mixture 
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4.5. Clinical Studies 
Population and Sample:  
 
         The population consists of paediatric patients attending the OPD of      
AyothidossPandithar Hospital, National Institute of Siddha, Chennai - 47.  The sample 
consists of 1-3 years age group fulfilling any four of the inclusion criteria and none of the 
exclusion criteria.  
 
Sample size : 30 Patients  
Study place : OPD &IPD of Ayothidosspandithar Hospital,  
   National Institute of Siddha, Tambaram sanatorium, Chennai – 47. 
 
 Inclusion criteria: 
Age 1 to 3 years 
Sex: Both male and female children. 
Children with minimum four clinical symptoms such as 
[ 
1. Constipation 
2. Poor appetite 
3. Borborygmus/stomach pain 
4. Cough 
5. Fever 
6. Yawning 
Exclusion criteria 
1. High temp > 102 F 
2.  Intolerable stomach pain 
3. Constipation more than 1 week 
4. Patient not willing to give biological samples whenever needed 
 
Withdrawl criteria: 
1. Occurrence of any adverse effect 
2. Poor patient compliance &defaulters. 
3. Patient turned unwilling to continue in the course of clinical trial. 
4. Exacerbation of symptoms 
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Study design     :  An Open clinical trial.  
Study duration     :  12 Months 
Name of the trial drug  :  Chukkunei (internal) and Chinni thuvalai (external)  
Dosage of drugs     :   5ml(od) at morning  
           Chinni thuvalai for 3 days at morning 
 
A.Clinical Assessment  
Clinical assessment  were done with reduction of following clinical symptoms and also 
using Bristol Stool Chart. 
 Constipation 
 Poor appetite 
 Borborygmus/Stomach pain 
 Fever 
 Cough 
 Yawning 
 
B.Siddha Method of Assessment 
 Clinical aasessment also done using the following variables according to Siddha 
Methodology 
 Nilam 
 Kaalam 
 Uyirthathukkal 
 Udalthaathukkal 
 Envagaithervugal 
 
Study Enrollment: 
 
1.  In this study, patients reporting at the NIS OPD with the four or more clinical 
symptoms were examined clinically for enrolling in this study based on the inclusion 
and exclusion criteria. 
2. The patients who were to be enrolled in this study were informed (Form VI) about 
the study, experimental medicine, possible outcomes and the objectives of the study 
in the language and terms understandable to them and to their informants. 
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3. After ascertaining the patient and informant willingness, informed consent was  
obtained in writing from them in the consent form (Form II). 
 
4. All these patients were given unique registration card in which patients‟ Registration 
number of the study, Address, Phone number and Doctors phonenumber etc. will be 
given, so as to report easily communication for the sake of the patient. 
 
5. Complete clinical history, complaints and duration, examination findings - all were   
be recorded in the prescribed Proforma in the history and clinical assessment forms 
(form IV) separately. Screening Form- I will be filled up; Form III was be used for 
recording the patients‟ history, clinical examination of symptoms and signs 
respectively. 
 
6. Patient were advised to take the trial drug and appropriate dietary advice (Form X) 
was given according to the patients‟ perfect understanding. 
 
Conduct of the Study: 
 
The trial drug “Chukku nei”(Internal) and “Chinni thuvalai” (External) were given 
for 3 days. For OP patients the clinical assessment was done and prognosis noted on 0
th
day 
and 4
th
 day. For IP patients the drug was provided and prognosis noted and clinical 
assessment was done on 1
st
 day itself. 
 The patients were treated with trial drugs Chinni thuvali (external therapy) at 
morning, after finishing the therapy patients were adviced to take bath with warm water. 
Then the trial drug Chukku nei was given orally with a dosage of 5 ml. OPD patients were 
instructed to come regularly for 3 days and advised to follow the diet. 
 
Data Managment: 
 
         After enrolling the patient in this study, a separate file for each patient was opened and 
all forms were filed in the file. When the patient visits OPD during the study period, the 
respective patient file was taken and necessary recordings made at the assessment form or 
other suitable form.The screening forms werefiled separately. 
 
The Data recordings were monitored for completion and any adverse event by HOD 
and data logical recording and completeness monitored by statistician (Sr.Research Officer 
(Statistics) .All forms were further scrutinized in presence of Investigator by Sr.Research 
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Officer (SRO) for logical errors and incompleteness of data before entering onto computer 
to avoid any bias. No modification in the results is permitted for unbiased report. 
If any missed data found during the study, it was collected from the patient, but the 
time related data not be recorded retrospectively. All the collected data were enteredonto 
computer using MS access software.Investigator was trained to enter the patient data and 
cross checked by SRO. 
 
Advese Effect/Serious Effect Management: 
 
If the trial patient develops any adverse reaction, he/she would be immediately 
withdrawn from the trial and proper management will be given in OPD of National institute 
of siddha and the same will be reported to regional pharmacovigilance center. 
 
Ehical Issues: 
1. No other external or internal medicines were used. 
2. The data collected from the patient‟s informant was recorded. The patient‟s 
informant was informed about the diagnosis, treatment and follow-up.  
3. After the consent of the patient‟s informant (through consent form), patient was 
enrolled in the study 
4. Informed consent was obtained from the patient‟s informant explaining in the 
understandable language to the patient‟s informant. 
5. Treatment was provided free of cost. 
6. In conditions of treatment faliure, adverse reactions, patients will be given             
alternative treatment at the National Institute of Siddha with full care. 
 
Data Collection Forms:- 
Form I        Screening & Selection Proforma 
Form II       Consent Form 
Form III      Case report form 
Form IV      AssessmentForm 
Form V       Patient Information Sheet 
Form VI     Drug compliance 
Form VII     Withdrawal 
Form VIII    Adverse reaction 
Form IX     Pharmaco vigilance 
Form X     Dietary form 
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CHAPTER V 
 
 5. RESULTS AND OBSERVATIONS 
 
Preclinical studies: 
5.1. Physicochemical analysis of chukku nei 
 
Table No.5.1.1Final test report 
 
State Liquid 
Appearance Reddish Brown 
Nature Viscous Liquid  
Odor Strong Characteristic  
 
Table No. 5.1.2 
 
S.No.             Specific Test Results 
1  Specific gravity 0.9471 
2 Viscosity at 50c (pa s) 33.019 
3 Refractive index 1.46 
4 Weight per ml (gm/ml) 0.068 gm/ml 
5 Iodine value (mg I2/g) 172.08 
6 Saponification value (mh of KOH to 
sdaponify 1gm of fat) 
262.43 
7 PH 4 
8 Acid value mg KOH/g 3.104 
9 Peroxidase  value mEq/kg 2.325 
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5.2. Phytochemical analysis of chukku nei 
 
Table no. 5.2.1 
S.NO        TEST OBSERVATION 
1 ALKALOIDS + 
2 FLAVANOIDS + 
3 GLYCOSIDES - 
4 STEROIDS + 
5 TRITERPENOIDS + 
6 COUMARIN - 
7 PHENOL - 
8 TANIN - 
9 PROTEIN - 
10 SAPONINS + 
11 SUGAR - 
12 ANTHOCYANIN - 
13 BETACYANIN + 
 
5.2.2 Result of Phytochemical Analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig no.1Test for Alkaloid   Fig no.2 Test for Steroid Fig no.3 Test for Flavanoid 
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Fig no.4     Fig no.5                 Fig no. 6 
Test for Beta cyanin  Test for Saponin                     Test for Triterpenoids 
 
5.3. Biochemical Analysis of chukku nei 
Table no.5.3.1 Results of Acid radicals studies 
S.NO Parameter Observation Result 
1 Test for Sulphate Cloudy appearance Present Positive 
2 Test for Chloride 
 
-  
Negative 
3 Test For Phosphate 
 
-  
Negative 
4 Test For Carbonate   
 
 
Cloudy appearance present 
 
       positive 
 
5 Test For Nitrate  
- 
Negative 
6 Test for Sulphide  
- 
Negative 
7 Test For Fluoride &oxalate 
 
 
- 
Negative 
8 Test For Nitrite 
 
- 
 
Negative 
9 Test For Borax 
 
- Negative 
 
Interpretation 
  The acidic radicals test shows the presence of   Sulphate, Carbonate. 
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Table no.5.3.2 Results of basic radicals studies: 
 
S.NO Parameter Observation Result 
1 Test for Lead - Negative 
2 Test for Copper - Negative 
3 Test For Aluminium. - Negative 
4 Test For Iron. Mild red colour positive 
5 Test For Zinc - Negative 
6 Test for Calcium Cloudy appearance and white 
precipitate  present 
Positive 
7 Test For Magnesium White precipitate obtained Positive 
8 Test For Ammonium - Negative 
9 Test For Potassium - Negative 
10 Test For Sodium - Negative 
11 Test For Mercury - Negative 
12 Test For Arsenic - Negative 
 
Interpretation 
 The basic radical test shows the presence of calcium, Magnesium, Carbonate, 
Iron and absence of heavy metals such as lead, arsenic and mercury. 
 
Table No.5.3.3 Miscellaneous: 
S.NO Parameter Observation Result 
1 Test for Starch - Negative 
2 Test for Reducing sugars - Negative 
3 Test For Alkaloids. Yellow colour developed Positive 
4 Test For Tannic acid. - Negative 
5 Test for unsaturated compounds - Negative 
6 Test for Amino acid - Negative 
7 Test For Type of compounds - Negative 
Interpretation 
The Miscellaneous test shows the presence of Alkaloids 
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5.4. Fluorescence Analysis 
Table no.5.4.1 fluorescence analysis 
 
S.No Experiment Visible light Short  
UV – Light 
254 nm 
Long  
UV – Light 
365 nm 
1 Sample + Conc. Hcl Yellow Yellow Fluorescent Yellow 
2 Sample + Conc. 
Sulphuric Acid 
Greenish brown Dark reddish 
brown 
Brown 
3 Sample + Conc. Nitric 
acid 
Creamy white Creamy yellow Fluorescent yellow 
4 Sample + Sodium 
hydroxide in water 
Whitish yellow Fluorescent 
yellow 
Fluorescent yellow 
5 Sample + Ferric 
chloride 
Brownish orange Fluorescent 
green 
Orange 
6 Sample + glacial acetic 
acid 
Creamy white Lime Yellow Yellow 
 
Fig no.5.4.2 Thin Layer Chromatography (TLC) 
 
TLC Analysis at 254 nm                               TLC Analysis at 366 nm 
 
 
 
 
 
 
 
Fig no. 5.4.3 High Power Thin Layer Chromtography (HPTLC) 
 
 
Table no. 5.4.4  HPTLC finger print 
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HPTLC finger printing analysis of the sample Chukku nei reveals the presence of 
ten prominent peaks corresponds to presence of ten versatile phytocomponents present with 
in it. Rf value of the peaks ranges from 0.09 to 0.91. Further the peak 4 occupies the major 
percentage of area of 30.12 % which denotes the abundant existence of such compound. 
Followed by this peak 2 and 7 occupies the percentage area of 19.64 and 14.61%. 
 
5.5. Heavy metal analysis of chukku nei 
Table no.5.5.1 
F THE 
HEAVY METAL 
 ABSORPTION 
MAX 
RESULT  
ANALYSIS 
MAXIMUM 
LIMIT 
MERCURY 253.7 nm BDL 1 PPM 
LEAD 217.0 nm 0.010PPM 10 PPM 
ARSENIC 193.7 nm BDL 3 PPM 
CADMIUM 228.8 nm 0.005 PPM 0.3 PPM 

Results of the present investigation has clearly shows that Chukku nei has no traces 
of Mercury and Arsenic.The level of lead and cadmium was found to be 0.010 ppm and 
0.005 ppm.Reported heavy metals (lead and cadmium) seems very low when compare to 
the allowed recommended limit. 
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5.6 Sterlity Test by pour plate method 
Table no.5.6.1 
Test Result Specification 
As per 
AYUSH/WHO 
Total Bacterial Count Absent NMT 10
5
CFU/g 
As per AYUSH 
specification Total Fungal Count Absent NMT 103CFU/g 
 
No growth / colonies were observed in any of the plates inoculates with the test sample. 
5.7. Test for specific pathogen 
Table no.5.7.1 
Organism Specification Result Method 
E-coli Absent Absent  
As per AYUSH 
specification 
Salmonella Absent Absent 
Staphylococcus Aureus Absent Absent 
Pseudomonas Aeruginosa Absent Absent 
 
No growth was observed after incubation period. Reveals the absence of specific pathogen. 
 
5.8. Analysis of organochlorine pesticide, organophosphorus pesticide and pyrethroid 
 
The results showed that there were no traces of pesticides residues such as Organo 
chlorine and Organo phosphorus Pesticides in the sample CN. Further sample shows the 
presence of Cypermethrin belongs to pyrethroid type of pesticide at the concentration of 0.1 
mg/kg which was low when compare the AYUSH prescribed limit of 1mg/kg. 
 
5.9. Test for Aflotoxin 
The results shown that there was no spots were been identified in the test sample 
loaded TLC plated when compare to the standard indicates that he sample were free from 
Aflatoxin B1, Aflatoxin B2, Aflatoxin G1, Aflatoxin G2.  
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5.10. Pharmacological Activity :    In-vitro carminative Activity 
Result Analysis 
The carminative profiling of the test sample Chukku nei was evaluated on basis of the 
amount of cabondioxide evolved from the reaction mixture with varying volume of CN. The 
amount of cabondioxide {g} produced by the 5ml of the sample CN was found to be for 10 
ml of sample it was (6.87 ± 1.21), 20 ml of sample it was (10.1 ± 1.06) and 40 ml of sample 
it was (19.13 ± 1.23). Each value represents the mean ± SD. N=3. It was concluded that the 
drug possesses promising carminative activity in the tested medium which was measured as 
an index of mass of CO2 released from the medium.  
Table no.5.10.1 
Volume of Test Sample Mass of CO2 in gm 
0 (6.87 ± 1.21) 
20 (10.1 ± 1.06) 
40 (19.13 ± 1.23) 
 
Clinical Studies 
30 Patients with confirmed diagnosis of with satisfying the inclusion criteria were 
enrolled after obtaining written informed consent and were to receive Chukku nei with 
dosage of 5 mlod for 3 daysand chinni thuvalai as external therapy. 
 
Results were observed with respect to the following criteria: 
1. Age 
2. Sex 
3. Religion 
4. Parent‟s Socio Economic Status    
5. Diet 
6. Nilam 
7. Paruvakaalam 
8. Uyirthathukkal 
9. Ezhuudalkattugal 
10. Envagaithervugal 
11. Naadi 
12. Neikuri 
13. Clinical features 
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Table1. Distributions of patients with Kattu Mantham according to Age  
 
S.NO AGE NO.OF.CASES PERCENTAGE% 
1. 1-2 Years 16 53% 
2. 2-3Years 14 46% 
 
 
 
  
 
 
Inference: 
 Out of 30 patients, 53 % of cases were within 1-2years, 46 %of cases were within 2-
3 years. (Table1) 
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Table2.Distributions of patients with Kattu mantham according to Gender 
 
S.No Sex No of Cases Percentage% 
1. Male Child 13 43% 
2. Female Child 17 56.6% 
 
 
 
 
 
 
 
 
Inference: 
Out of 30 patients 43% were male children and 56.6% were female children. (Table 
2) 
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Table.3. Distribution of patients with Kattu mantham according to Religion status 
 
            Religion         No of Cases           Percentage 
         Hindu             28               93.3% 
         Christian             2               6.6% 
         Muslim             0               0 
 
 
 
 
 
 
 
Inference (Religion): 
According to Religion, Hindu was reported in 93.3% of cases, Christian was 
reported in 6.6% of cases and No cases were reported from Muslim community (Table3). 
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Table 4. Distribution of patients with Kattu mantham according to Socio economic 
status 
 
S.No 
Socio-economic 
Status 
No of Cases Percentage% 
1. High Income group 3 10 
2. 
Middle Income 
group 
15 50 
3. Poor Income group 12 40 
 
 
 
 
 
 
 
Inference: 
 About 40% patients were under lower income group, 50% patients were 
under middle income group and 10% patients were under high income group.  The highest 
incidence occurred in middle income group.(Table 4). 
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Table 5.Distribution of patients with Kattu mantham according to Diet reference 
 
S.NO FOOD HABITS NO OF CASES PERCENTAGE% 
1. Vegeterian 9 30% 
2. Non-Vegeterian 21 70% 
 
 
 
 
 
 
 
Inference: 
 According to diet habit, 30% of children are taking Vegetarian food and 70% of 
them from Non Vegetarian group (Table 5) 
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Table.6. Distribution of patients with Kattu mantham according to Nilam 
Nilam No of cases Percentage% 
Kurinji 0 0 
Mullai 0 0 
Marutham 0 0 
Neithal 30 100% 
Paalai 0 0 
  
 
 
 
 
 
Inference: 
Among 30 patients, 100 % were from Neithal land, 0% from Marutham land, 0 % 
from Mullai land and 0% from Kurinji land.(Table 6) 
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Table.7. Distribution of patients with Kattu mantham according to Paruvakalam 
S.No Paruvakaalam No. of cases Percentage 
1. Karkaalam (Avani – puratasi) 0 0 
2. Koothirkaalam (Iyppasi – karthikai) 1 3.3% 
3. Munpani (Markazhi – Thai) 15 50% 
4. Pin pani (Masi – Panguni) 14 46.6% 
5. Elavenil (Chitirai, Vaigasi) 0 0 
6. Mudhuvenil (Aani, Aadi) 0 0 
 
 
 
 
 
 
 
Inference: 
According to paruva kaalam, high incidence of cases 50% were reported in 
munpanikalam, 46.6% cases were reported in  pinpani kalam and 1% in koothirkalam 
.(Table 7) 
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Table 8.a. Distribution of patients with Kattu mantham according to derangement of 
Vatham 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inference: 
According to vatham, Abanan, viyanan, samanan, kirukaran and devathathan were  
affected in 100% of cases and Udhanan was affected in 93.3% of cases. The remaining 
piranan, nagan, koorman were not affected in any of the cases. (Table 8a). 
 
Sl.No. Type of Vatham No. Of Cases Percentage 
1. Piranan 0 0 
2. Abanan 30 100% 
3. Viyanan 30 100% 
4. Uthanan 28 93.3% 
5. Samanan 30 100% 
6. Nagan 0 0 
7. Koorman 0 0 
8. Kirukaran 30 100% 
9. Devathathan 30 100% 
10. Thananjeyan 0 0 
0
100 100
93.3
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100 100
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Table 8.b. Distribution of patients with Kattu mantham according to derangement of 
Pitham 
S.No Types of pitham No.of Cases Percentage 
1. Analapitham 30 100% 
2. Ranjagam 0 0 
3. Saathagam 0 0 
4. Prasagam     0 0 
5. Alosagam 0 0 
 
 
 
 
 
 
 
Inference: 
Out of 30 patients, according to Pitham, Analapitham was affected in  100% of cases 
(Table 8b). 
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Table 8.c. Distribution of patients with Kattu mantham according to dearrangement of 
Kabam 
 
S.No Types of Kabham No.of Cases Percentage 
1. Avalambagam 30 100% 
2. Kilethagam 30 100% 
3. Pothagam 0 0 
4. Tharpagam 0 0 
5. Santhigam 0 0 
 
 
 
 
 
 
 
Inference:  
According to Kabam, Avalambagam and Kilethagam were affected in 100% of 
cases  (Table8c). 
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Table 9. Distribution of patients with Kattu mantham according to derangement of 
Ezhu Udarkattugal 
S.No Udarkattugal No.of Cases Percentage 
1. Saaram 30 100% 
2. Senneer 0 0 
3. Oon 0 0 
4. Kozhuppu 0 0 
5. Enbu 0 0 
6. Moolai 0 0 
7. Sukkilam  / Suronitham 0 0 
 
 
 
Inference:  
Out of 30 patients, Saram was affected in 100% of cases. All other udarkattugalwas 
not affected in any cases (Table 9). 
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Table 10. Distribution of patients with Kattu mantham according to derangement of 
Enn vagai thervugal 
S.No Enn Vagai Thervugal No of Cases (Percentage%) 
1 Naa 10 (33.3%) 
2 Niram 0 
3 Mozhi 0 
4 Vizhi 0 
5 Malam 30 (100%) 
6 Moothiram 
0 
7 Sparisam  
4 (13.3%) 
8 Naadi  
30 (100%) 
 
 
 
 
 
Inference: 
Out of 30 cases, Malam was affected in 100% of cases, Sparism was affected in  
13.3% of cases, Naa was affected in 33.3% of cases.(Table 10) 
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Table 11. Distribution of patients with Kattu mantham according to observation of 
Naadi 
Naadi No of Cases Percentage 
Vathapitham 21 70% 
Vathakabam 0 0 
Pithakabam 0 0 
Pithavatham 9 30% 
Kabapitham 0 0 
Kabavatham 0 0 
 
 
 
 
 
 
 
Inference (Naadi): 
In Naadi, Vathapitham was observed in 70 % of cases, Pithavatham was observed in 
30 % of cases 
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Table 12. Distribution of patients with Kattu mantham according to observation of 
Neikuri analysis 
 
S.No 
Character of 
urine 
Neikuri 
Reference 
No.of Cases Percentage 
1. 
Spreads like 
snake 
Vatha Neer 
20 
66.6 
2. 
Spreads like 
ring 
Pitha Neer 
9 
30 
3. Static as pearl Kaba Neer 1 3.3 
 
 
 
 
 
Inference 
According to Neikuri, Vatha neer was observed in 66.6% of cases, pitha neer was 
observed in 30% of cases, Kaba neer was observed in 3.3 % of cases (Table 12) 
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Table – 13 
Distribution of clinical symptoms of Kattu mantham 
 
 
 
 
 
 
Inference 
Among the 30 cases, 100% of the patients had constipation, 83.3 % had 
borborygmus/stomach pain, 100% had poor appetite, 13.3% had fever, 93.3% had cough. 
No patients (0%) was reported with yawning 
 
 
 
S.No Signs and Symptoms No.of cases (out of 30) Percentage 
1 Constipation 30 100% 
2 Poor appetite 30 100% 
3 Borborymus/stomachpain 25 83.3% 
4 Fever 4 13.3% 
5 Cough 28 93.3% 
6 Yawning 0 0 
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Table – 14 
Distribution of patients with Kattu mantham according treatment results obtained 
Clinical Features 
Before 
Treatment 
Percentage 
(%) 
After 
Treatment 
Percentage 
(%) 
Constipation 30 100% 9 30% 
Poor appetite 30 100% 7 23.3% 
Borborygmus/stomach 
pain 
25 83.3% 4 13.3% 
Fever 4 13.3% 0 0 
Cough 28 93.3% 10 33.3% 
Yawning 0 0 0 0 
  
 
 
Inference: 
Out of the 30 cases, the signs and symptoms like constipation 100 %, poor 
appetite100%, borborygmus/stomach pain 83.3%, fever 13.3%, cough 93.3% were reduced 
into 30%, 23.3%, 13.3%, 0%, 33.3% reuced respectively. These results were based on the 
clinical improvements observed. 
 
 
 
 
100 
  
 
For clinical studies 
Statistical analysis: 
 All collected data were entered into MS Excel software using different columns as 
variables and rows as patients. STATA software was used to perform statistical analysis. 
Basic descriptive statistics include frequency distributions and cross- tabulations were 
performed. Bar diagram, Pie charts were used to describe the value of different variables for 
pictorial representation. The quantity variables were expressed as Mean and standard 
deviation and qualitative data as percentage. A probability value of less than 0.05 was 
considered to indicate as statistical significance. Paired„t‟ test was performed for 
determining the significance between before and after treatment. 
Paired Samples Statistics 
 
 
S. No 
 
 
Treatment 
 
 
 
 
Mean + SD 
95% Confidence 
Interval of the 
Difference 
 
 
Significance 
(t,p) 
Lower Upper 
1 Before 1.27+0.450 1.1 1.43    t = -9.379 
   p<0.001 
2 After 2.53+0.776 2.24 2.82 
 
 
RESULT 
1. The mean + standard deviation of clinical symptoms, before and after treatment 
were 1.27 + 0.450 and 2.53 + 0.776 respectively. which is statistically significant t-
value = - 9.379, P value P<0.00 
2. P<0.05- reject null hypothesis  
3. There is a significance between before and after treatment 
4.  The result shows 70% reduction in the clinical symptoms of patients after treatment 
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CHAPTER VI 
 
6. DISCUSSION 
 
 Kattu mantham is one of the most common illness in day to day life activities in 
children. Kattu mantham is defined as passing stools fewer than 2 times per week with 
abdominal discomfort, loss of appetite, lethargy sometimes with or without the symptoms of 
fever cough, nausea and vomiting. The clinical features of kattu mantham can be correlated 
to constipation in modern science. The aim of the trial was to evaluate the therapeutic effect 
of the drug to relieve constipation. 
 
The simple and effective drug Chukku nei (internal) and Chinni thuvalai (external) 
which has been mentioned in siddha literature for the management of kattu mantham were 
selected and the study was conducted after the preparation of protocol further screened by 
screening commite of national institute of siddha and the trial was approved by institutional 
ethical committee (IEC) with approval no.NIS/IEC/2016/11-21/14.10.2016. Then the trial 
drug was registered in Clinical Trial Registry of India (CTRI) with Registration No: 
CTRI/2017/06/008801 
 
The trial drugs were prepared by the author in the Gunapadam Practical Laboratory 
of National Institute of Siddha, after getting proper authentication of raw drugs from the 
Medicinal Botany Department at NIS, chennai 47. The trial drug was prepared by the 
standard operating procedure as mentioned in the protocol. 
 
The biochemical qualitative and quantitative analysis of drugs were performed in 
Biochemistry Lab of NIS, Chennai. The safety of the trial drug usage through the 
biochemical analysis were also ensured during the study. The patients were recruited for the 
trial basd on inclusion and exclusion criteria and after getting the consent from the parent 30 
patients were included in this study. 
 
30 cases were treated in OPD of Ayothidoss Pandithar Hospital, National Institute of 
Siddha. Separate proforma was maintained for every patient. Daily progress were 
monitored. 
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 The patients were treated with trial drugs Chinni thuvali (external therapy) at 
morning, after finishing the therapy patients were adviced to take bath with warm water. 
Then the trial drug Chukku nei was given orally with a dosage of 5 ml. OPD patients were 
instructed to come regularly for 3 days and advised to follow the diet. 
The results observed during the study period were discussed below 
Preclinical studies 
Physicochemical analysis: 
 
Acid value 
 The Acid value is used to quantify the substance, which is an index of free fatty acid 
content due to enzymatic activity. The acid value of chukku nei was found to be 3.104 mg 
KOH/g. 
 
Peroxide value 
The peroxide value is a measure of active oxygen in the oil and high starting level of 
peroxide value indicates the low quality of the oil. If the peroxide level is higher than 
10meq/kg means that the stability of the oil is less and has a shorter shelf life. In this study 
the peroxide value is 2.325 meq/kg and it iscomparatively very low.therefore it is cleared 
that the oil has long shelf life.  
 
Saponification value 
The saponification value is 262.43 mh KOH/g to neutralize the fatty acids resulting 
from the complete hydrolysis of 1gm of sample. 
 
Iodine value 
Iodine value is used to evaluate the unsaturated level in fatty acids. A higher iodine 
value indicates the higher degree of unsaturation. In this study the iodine value is 172.08 
mgI2/g. Therefore, it is not too much hard in texture. 
 
Determination of PH 
 Strongly acidic nature of the drug can cause the harmful effects to the body. So the 
screening for the pH is important for the drug. It represents the chemical nature of the drug 
and the site of absorption of non polar drug. The pH of Chukku nei is found to be 4 that is 
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weakly acidic and safe in pH. The weakly acidic drugs are rapidly absorbed from stomach. 
So the trial drug Chukku nei can act rapidly on oral administration. 
 
Biochemical analysis 
The Bio chemical analysis of trial medicines showed presence of calcium, magnesium, 
sulphate, zinc, Iron and alkaloids. Presence of tannic acid – drug  containing  tannins posses 
anti ulcer activity, it reduce symptoms of Abdomen discomfort. Presence of calcium – 
calcium ions significantly increase the drug release.  It enhance the drug to absorb well. 
 
Heavy metal analysis  
Results shows that Chukku nei has no traces of Mercury and Arsenic.Lead and 
cadmium seems very low when compare to the allowed recommended limit. So there is no 
toxicity to the children while intake of medicine. 
 
Analysis of organochlorine pesticide, organophosphorus pesticide and pyrethroid 
There were no traces of pesticides residues such as Organo chlorine, Organo 
phosphorus Pesticides and pyrethroids. 
 
Test for Aflatoxin 
The results shown that there was no spots were been identified in the test sample 
loaded TLC plated when compare to the standard indicates that the sample were free from 
Aflatoxin B1, Aflatoxin B2, Aflatoxin G1, Aflatoxin G2.  
  
Pharmacological Activity - In Vitro carminative Activity  
In-vitro carminative activity of the Chukku nei  was evaluated by modified method 
of Swapnil Sharma et al clearly indicates the test drug Chukku nei. The carminative 
profiling of the test sample Chukku nei was evaluated on basis of the amount of 
cabondioxide evolved from the reaction mixture with varying volume of Chukku nei.The 
maximum amount of Cabondioxide {g} produced by the 20ml of the sample Chukku nei 
wasfound to be (12.53 ± 0.53) and 40 ml of sample it was (16.17 ± 0.75) . It was concluded 
that the drug possesses promising carminative activity in the tested medium which was 
measured as an index of mass of CO2 released from the medium.  
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Patients Demographic Parameters 
Age: 
In the present study, Out of 30 patients, 53.3% of cases were within 1-2 years, 46.6% 
were  within2-3 years. 
Sex: 
 Out of 30 patients 43.3% patients were male children and 56.6 % patients were female 
children. Female children affected more than male children. 
Socio-economic status: 
About 40% patients were under lower income group, 50% patients were under middle 
income group and 10%patients were under high income group.  The highest incidence 
occurred in middle income group. 
 
Seasonal variation:  
According to paruva kaalam, high incidence of cases 50% were reported in 
munpanikalam, 46.6% cases were reported in  pinpani kalam and 1% in koothirkalam. 
 
Food habits: 
According to food habits 30% of children are taking Vegetarian food and  70% of them 
from Non Vegetarian group. The highest incidence of cases was observed in Non vegetarian 
diet  
 
Nilam: 
Among 30 patients, 100% of cases from Neithal land. 
 
Vali (Vatham) 
Due to the derangement of vatha the following symptoms occur. Abanan was affected  
in 100% of cases and cause constipation .Viyanan was affected in 100%, Samanan was 
affected in 100% of cases. Uthanan was affected in 93.3% of cases cause cough, Kirukaran 
was affected in 100% cause cough, Poor appetite and devathathan was affected in  100%  
cause general body weakness. 
 
Azhal (Pitham) 
Analapitham was affected in 100% of cases cause poor appetite. 
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Iyyam (Kabam): 
Avalambagam and Kilethagam was affected in 100 % of cases cause poor appetite. 
 
Ezhu udarkattugal: 
In Ezhu udar kattugal, Saram was affected in 100% of cases due to Cough and Poor 
appetite. 
 
Envagai thervugal: 
 
In envagai thervugal, Na was affected in 33.3% of cases, Malam was affected in 100% 
of cases due to constipation. Sparisam was affected in 13.3% of cases due to Low grade 
fever. Naadi was affected in 100% of cases. 
 
Naadi: 
Vathapitham was observed in 70% of cases, Pithavatham was observed in 30% of cases. 
According to naadi, high distribution observed in vali Azhal, Azhal vali naadi. In siddha 
literature, the character of vali Azhal is due to poor appetite, indigestion and nausea. 
 
Neerkuri: 
Regarding moothiram, neerkuri showed straw coloured urine in all cases. 
 
Neikuri: 
In the present study, vatha neer was observed in 66.6% of cases, pitha neer was 
observed in 30% of cases and kaba neer was observed in 3.3% of cases. According to this 
neikuri, vatham was dominately affected. 
 
Clinical features: 
The clinical feature of Kattu mantham may be correlated with clinical 
manifestations of Constipation. In accordance with the clinical features of kattu mantham 
among the 30 cases, Among the 30 cases, 100% of the patients had constipation, 83.3 % had 
borborygmus/stomach pain, 100% had poor appetite, 13.3% had fever, 93.3% had cough. 
No patients (0%) was reported with yawning 
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Improvement in clinical features: 
 Out of the 30 cases, the signs and symptoms like constipation 100 %, poor 
appetite100%, borborygmus/stomach pain 83.3%, fever 13.3%, cough 93.3% were reduced 
into 30%, 23.3%, 13.3%, 0%, 33.3% reuced respectively. These results were based on the 
clinical improvements observed. 
 
Improvement in symptoms of Constipation using Bristol Stool Chart 
 
Before treatment  
Out of 30 cases, 22 (73.3%) patients had severe constipation and 8 (26.6%) patients 
had mild constipation. 
After treatment 
 Out of 22 (73.3%) in severe constipation cases, 5 (16.6%)  had not passed stools, 
remaining 17 (56.6%) patients were passed stools normally.  
Out of 8 (26.6%) in mild constipation cases, 4 (13.3%) patients were passed stools 
normally remaining 4 (13.3%) patients had mild constipation. 
Totally out of 30 cases, 21 (70%) had passed stools normally whereas remaining 5 
(16.6%) patients had not passed stools and 4 (13.3%) patients had mild constipation. 
 
Statistical analysis  
The clinical efficacy of the drug was analyzed statistically on all the symptoms 
mentioned in the assessment criteria  ( t-value = - 9.379, P<0.00 )are statistically significant 
 
These results were based on the clinical improvements observed. The reduction of 
clinical symptoms after the treatment is significant. The reduction in the symptoms is 70% 
from the start of the treatment. Hence the medicine is good in effective. 
 
. 
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CHAPTER VII 
 
7. SUMMARY  
 
The disease Kattu mantham was taken for the clinical study with Chukku nei 
(Internal) and Chinni thuvalai (External) after scrutinizing the research protocol by the 
Screening committee of National Institute of Siddha.   
 
The Clinical studies were carried out after obtaining proper permission from 
approval IEC of National Institute of Siddha IEC No: NIS/IEC/2016/11-21/14.10.2016.  
The trial registered in Clinical trial Registry of India with Reg .No.CTRI//2017/06/008801. 
The Authentication of ingredients of the trial drug was done by Medicinal Botanist, 
National Institute of Siddha, Chennai.  
 
Purification of raw drugs and preparation of trial drug was done in Gunapadam 
Laboratory of National Institute of Siddha, Chennai. Biochemical Qualitative analysis of 
trial drug was done in Biochemistry laboratory of National Institute of Siddha, Chennai. 
The biochemical analysis of trial medicine showed the presence of calcium, magnesium, 
sulphate, Iron and alkaloids.  
 
Physicochemical analysis and In vitro carminative activity of Chukku nei were done 
in Noble research solutions, Chennai. The physicochemical analysis showed the trial drug is 
in appropriate consistency for trial study and it possesses promising carminative activity in 
the tested medium which was measured as an index of mass of CO2 released from the 
medium. 
 
All the 30 samples were recruited for this study from OPD of Kuzhandhai 
Maruthuvam department at Ayothidoss Pandithar Hospital of National Institute of Siddha. 
The patients with Kattu mantham were recruited based on Inclusion and Exclusion criteria 
and a detailed study was done. Separate proforma was maintained for each patient along 
with progress chart to monitor the prognosis.       
 
The clinical efficacy of the trial drugs were analyzed statistically on all the 
symptoms mentioned in the assessment form. (t-value = - 9.379 and  P<0.00 are statistically 
significant). The result shows that 70% reduction in the clinical symptoms and thus proves 
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the efficacy of the medicine. The patients have not complained of any adverse effects or 
difficulties during the course of treatment. Thus the drug is found to be safe and effective in 
the management of Kattu mantham. So the trail drugs Chukku nei (Internal) and Chinni 
thuvalai (External) was clinically effective.  
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CHAPTER VIII 
 
8 .CONCLUSION 
 
The Siddha system of medicines has certainity with safer medications to treat 
children. The children  are in the age group of 1-3 years , who all diagnosed  (30 patients) 
Kattu mantham were treated with Chukku nei (internal) 5ml, once at morning as well as 
Chinni thuvalai (external) for 3 days in Kuzhandhai Maruthuvam OPD of National Institute 
of Siddha. 
 
The ingredients of the internal as well as extrernal medication are purely herbal and 
are easily available. The prepared medicine was palaptable and these compounds may serve 
as potentially useful drug at low cost. 
 
Review of literature showed that most of the ingredients in the trial drug has effect 
in gastro intestinal tract like laxative and carminative activity. Thus was helpful in treating 
Kattu mantham in my study. The Clinical trial proves the efficiacy of the trial drug were 
found to be significant by relieving constipation, poor appetite, abdominal discomfort 
etc. The study shows that the Good improvement was   found   in 70% of cases after 
treatment.  
 
The clinical trial conducted in the selected study group was satisfactory and in turn 
provided a further research and opportunity for new drug establishment in the management 
of Kattu mantham. 
 
Because of the encouraging result of above study, the drug Chukku nei (internal) 
and Chinni thuvalai (external) may be taken for larger study with more number of sample 
population in the treatment of   Kattu mantham. 
 
. 
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NATIONAL INSTITUTE OF SIDDHA, 
AYOTHIDOSS PANDITHAR HOSPITAL, 
CHENNAI – 600 047. 
 
                      DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
    CLINICAL   EVALUATION OF CHUKKU NEI (INTERNAL) AND CHINNI 
THUVALAI (EXTERNAL)  A SIDDHA DRUG  IN THE TREATMENT OF    
KATTU MANTHAM   (CONSTIPATION)   IN CHILDREN. 
                                                   SCREENING FORM -I 
1.  S.L No:       2. OP/ IP No:                        3. Name:          
4. Age:                  5.Gender:    6. Date of Enrollment:   
7.  Date of completion:              8.Informant:               9. Reliablity:   
 
INCLUSION CRETERIA: 
       YES NO 
Age: between   1 -  3 years 
 Constipation   
 Poor appetite        
 Stomach  pain / Borborygmus       
 Fever     
 Cough   
 Yawning      
 
EXCLUSION CRITERIA 
 High temp > 102ºF  
 Intolerable stomach pain 
 Constipation more than 1 week 
 
PATIENT SELECTED FOR TRIAL  
IF YES ADMITTED IN                  IP                         OPD 
 
Signature of Investigator :  Signature of Guide 
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NATIONAL INSTITUTE OF SIDDHA, 
AYOTHIDOSS PANDITHAR HOSPITAL, 
CHENNAI – 600 047. 
                      DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
    CLINICAL   EVALUATION OF CHUKKU NEI (INTERNAL) AND CHINNI 
THUVALAI (EXTERNAL)  A SIDDHA DRUG  IN THE TREATMENT OF    
KATTU MANTHAM   (CONSTIPATION)   IN CHILDREN. 
 CONSENT FORM –II   
CERTIFICATE BY INVESTIGATOR 
 I certify that I have disclosed all the details about the study in the terms readily 
understood by the parent/guardian 
Signature  _________________ 
Date   _________________ 
Name  ________ _________ 
CONSENT BY PARENT 
 I have been informed to my satisfaction, by the attending physician, the purpose of 
the clinical trial, and the nature of drug treatment and follow-up including the laboratory 
investigations to be performed to monitor and safeguard my son/daughter body functions. 
 I am aware of my right to opd my son/daughter out of the trail at any time during the 
course of the trail without having to give the reasons for doing so.  
I, exercising my free power of choice, hereby give my consent to include my 
son/daughter as a subject in the clinical trial of “CHUKKU NEI” (INTERNAL) and 
“CHINNI THUVALAI” (EXTERNAL) for the treatment of KATTU  MANTHAM 
(CONSTIPATION) in children 
Date :      Signature  __________________ 
      Name   __________________ 
      Signature of witness     ________________ 
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தேசி஬ சித்ே ஫ருத்துவ நிறுவனம் 
அத஬ோத்ேிேோச பண்டிேர் ஫ருத்துவ஫னன சசன்னன-47 
குழந்னே ஫ருத்துவத்துனை 
 
"சுக்கு ந஥ய்" (உள் நருந்து) நற்றும் "சின்஦ித்துவளை" (஧ி஫ நருந்து) ஧ரிகரிப்பு தி஫ள஦ 
கண்ட஫ியும் நருத்துவ ஆய்வு 
ஒப்புதல் ஧டிவம் –  ஆய்வாைபால் சான்஫ைிக்கப்஧ட்டது. 
஥ான் இந்த நருத்துவ ஆய்ளவ கு஫ித்த அள஦த்து வி஧பங்களையும் ந஥ானாைின் 
ந஧ற்ந஫ாருக்கு புரியும் வளகனில் எடுத்துளபத்நதன் எ஦ உறுதிஅைிக்கிந஫ன். 
நததி:                                                  ளகநனாப்஧ம்:  
இடம்:                                                ந஧னர்: 
 ந஥ானாைினின்ந஧ற்ந஫ார்ஒப்புதல்஧டிவம் 
 என்஦ிடம் இந்த நருத்துவ ஆய்வின் காபணத்ளதயும் நருந்தின் தன்ளந நற்றும் 
நருத்துவ வழி முள஫஧ற்஫ியும், இந்த நருத்துவத்ளத நதாடர்ந்து எ஦து குழந்ளதனின் 
உடல் இனக்கத்ளதக் கண்காணிக்கவும் அதள஦ ஧ாதுகாக்க ஧னன்஧டும் நருத்துவ 
ஆய்வுக்கூட ஧ரிநசாதள஦கள் ஧ற்஫ியும் திருப்தி அைிக்கும் வளகனில் ஆய்வுநருத்துவபால் 
விைக்கிகூ஫ப்஧ட்டது. 
 ஥ான் இந்த நருத்துவ ஆய்வின் ந஧ாது எப்ந஧ாது நவண்டுநா஦ாலும் என் 
குழந்ளதளன விடுவித்துக் நகாள்ளும் உரிளநளன நதரிந்திருக்கிந஫ன். 
 ஥ான் என்னுளடன சுதந்திபநாக நதர்வு நசய்யும் உரிளநளனக் நகாண்டு கட்டு 
நாந்தம் ந஥ாய்க்கா஦ "சுக்கு ந஥ய்" (உள்நருந்து) நற்றும் "சின்஦ித்துவளை" ( ஧ி஫நருந்து) 
஧ரிகரிப்புத் தி஫ள஦ கண்ட஫ியும் நருத்துவ ஆய்வுக்கு எ஦து குழந்ளதளன உட்஧டுத்த 
ஒப்புதல் அைிக்கிந஫ன். 
 
நததி;              ந஧ற்ந஫ார் ந஧னர்: 
இடம்:                                             ளகநனாப்஧ம்: 
சாட்சிக்காபர்ந஧னர்: 
உ஫வுமுள஫: 
ளகநனாப்஧ம்: 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL,CHENNAI – 600 047. 
  DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
 CLINICAL EVALUATION  OF CHUKKU  NEI (INTERNAL) AND CHINNI 
THUVALAI (EXTERNAL)   IN THE TREATMENT  OF    KATTU MANTHAM 
(CONSTIPATION) IN CHILDREN 
FORM III - CASE REPORT FORM 
Demographic data 
 Sl No : OP/IP No. Visit Date : (__/__/____) 
Name :  
Age    :  
Gender                Male             Female Date Of Birth : (__/__/____) 
Father/ Mother /Guardian Name : 
 
 
Father‟s Occupation : 
 
 
Father‟s Monthly  Income : 
 
 
Religion : 
 
 
 
Socioeconomic Status : 
 
 
Patient Informant : 
 
 
 
Postal Address : 
 
 
Contact no : 
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1. Complaints  and  duration  
 
  
 
2. History of  Present illness 
 
 
 
 
3. History of Past Illness  
 
 
 
History /Symptoms/Signs  Yes  No  If, Yes Details 
Any Similar Complains  
Dust Allergy 
 Hospitalization 
Any other        _____________ 
Family History 
Any Hereditary/ Familial Disease                      Yes                      No 
If Yes, Details -------- 
 
Immunization History  
Proper Immunization given  Yes                     No           ................................................. 
Food habits: 
   1.    Veg  2. Non-Veg  3. Mixed 
General   examination 
Pallor    YES   NO 
 Jaundice   YES              NO 
 Cyanosis   YES  N         NO 
Clubbing   YES              NO 
 Pedal oedema   YES              NO 
Lymph adenopathy  YES              NO 
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Vital signs:- 
1. Pulse rate /min  : _______ 
2. Heart rate /min  : _______ 
3. Respiratory rate /min  : _______ 
4. Temperature   : _______ 
 
Anthropometry:- 
          Height  : ______ cm 
          Weight  : ______ kg 
CLINICAL EXAMINATION:                  
    GASTRO INTESTINAL SYSTEM 
a) INSPECTION : 
 Shape of the abdomen    - Distended       Scaphoid 
 Abdominal movements -  Inverted         Everted 
 Scars                               -  Absent           Present 
 Visible veins                       - Absent           Present 
 Peristaltic waves              - Absent            Present 
 Pulsations                         - Absent            Present 
 Groin/scrotum                 -  Normal          Affected 
b)  PALPATION : 
 Absent                Present                Remarks 
Skin  turgor ______________ 
Abnormal  masses _____________ 
 Tenderness _____________ 
 
  C) PERCUSSION: 
Shifting dullness ______________ 
Fluid thrill ______________ 
Tympanic resonance note _____________ 
  d)  AUSCULTATION: 
Bowel sounds :  Absent         Normal              Increased               Decreased 
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Examination of Other systems; 
                                                           Normal                         Affected 
Cardio vascular system: 
Respiratory    system      
Musculo skeletal system:  
Central nervous system: 
Genito urinary system: 
 
SYSTEMIC EXAMINATION (SIDDHA) 
Nilam:-  
Kurinji  Mullai  Marutham N   Neithal     Paalai 
KaalaIyalbu:-  
 Kaarkalam   Koothirkaalam  Munpanikaalam 
 Pinpanikaalam              Illavenirkaalam            Muthuvenirkaalam 
Yaakai 
 Vatham  VathaPitham   VathaKabam 
 Pitham   Pithavatham   PithaKabam 
 Kabam   KabaVatham   KabaPitham 
 
Gunam 
Sathuvam   Rasatham   Thamasam   
 
Pori / Pulangal 
  Normal Affected                  Remarks 
Mei / unarvu                                                     ___________________ 
Vaai / suvai                                                      ___________________ 
Kan / parvai                   ___________________ 
Mooku / natram                  ___________________ 
Sevi / olli                  ___________________ 
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Kanmendhirium / Kanmavidayam 
       Normal     Affected   Remarks 
Kai / dhanam ___________________ 
Kaal / ghamanam ___________________ 
Vaai / vaku ___________________ 
Eruvaai / visarkam ___________________ 
Karuvaai / anantham ___________________ 
 
Uyir Thathukkal Vatham: 
   Normal   Affected  Remarks 
Pranan                                                                              ___________________ 
Abanan                                                                            ___________________ 
Viyanan                                                                  ___________________ 
Uthanan                                                                           ___________________ 
Samanan                                                                          ___________________ 
Nagan                                                                              ___________________ 
Koorman                                                                         ___________________ 
Kirukaran                                                                 ___________________ 
Devathathan                                                      ___________________ 
Dhanajeyan                                              ____________________ 
 
Pitham  
   Normal Affected  Remarks 
Analagam  ___________________ 
Ranjagam    ___________________ 
Saathagam   ___________________ 
Alosagam  ___________________ 
Prasagam ___________________ 
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Kabam 
   Normal Affected  Remarks 
Avalambagam    __________________ 
Kilethagam   __________________ 
Pothagam  __________________ 
Tharpagam   __________________ 
Santhigam  __________________ 
 
Udal Thathukkal 
   Normal Affected  Remarks 
Saaram _________________ 
Senneer  _________________ 
Oon _________________ 
 
Kozhuppu _________________ 
Enbu _________________ 
Moolai _________________ 
Sukilam / Suronitham   _________________ 
 
EnvagaiThervugal  
                           Normal  Affected  Remarks 
Naa 
 Niram _________________ 
 Thanmai _________________ 
 Suvai _________________ 
Niram _________________   
Mozhi   _________________ 
Vizhi  __________________ 
           Niram __________________ 
 Thanmai __________________ 
 Parvai __________________ 
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Sparisam 
Malam 
Niram    Normal Affected             _________________ 
 Nurai   Normal Affected _________________ 
 Elagal   Normal Affected __________________ 
 Erugal   Normal Affected __________________ 
Moothiram 
Neerkuri:       Niram   Normal Affected            _______________ 
  Edai   Normal Affected   ________________ 
  Nurai             Normal  Affected ________________ 
  Manam            Normal  Affected  ________________ 
  Enjal       Normal Affected   ________________ 
Neikuri: 
Vatham  _______________ 
  Pitham  _______________ 
  Kabam  _______________ 
                        Other              _______________ 
Naadi : 
Thani Nadi 
 Vadham  pitham  s          kabam 
 
Thontha Nadi 
Vathapitham                     Pithavatham           Pithakabam            Kabapitham 
Vathakabam                     Kabavatham      
 
Diagnosis   ----------------------------------------   
 
Admitted to trial: 1. Yes    2. No 
 If yes, S. No:  1.IP   2.OP 
 
DRUGS ISSUED:_____________ 
Date  : ___________________    Station : ___________                                                                             
Signature of  Investigaton; 
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FORM IV  PATIENT INFORMATION SHEET 
 
Name of Principal Investigator       :  ______________________________ 
Name of the institute                       :  National Institute of Siddha, 
                       Tambaram Sanatorium, 
                        Chennai-47. 
 
INFORMATION SHEET FOR PATIENTS PARTICIPATING IN THE OPEN 
CLINICAL TRIAL. 
 
I  ---------------------- Studying as PG Scholar in department of  Kuzhandhai  Maruthuvam at 
National Institute of  Siddha, Tambaram Sanatorium is doing a open clinical study on "Kattu 
Mantham" (Constipation).  In this regard I am in a need to ask you few questions about your child‟s 
illness. I will maintain confidentiality of your comments and data obtained. There will be no risk of 
disclosing your identity and no physical, psychological or professional risk is involved by taking 
part in this study. Taking part in this study is voluntary. No compensation will be paid to you for 
taking part in this study. 
           You have the liberty in taking part in the study or not to take part.you can choose not to 
answer a specific question. You may be benefited if you take part in this study. In addition to taking 
part in the study may be  benefit to the community, as it may help us to understand the disease 
elaborately and its potential problem and potential solutions. 
             All the medicines and other relevant Investigation procedures will be provided with free of 
cost. If you agree that your child to be a participant in this study, he/she will be included in the study 
primarily by signing the consent form and then  internal medicine  CHUKKU NEI” will be given  at 
a dose of  5 ml od at morning time and "CHINNI THUVALAI" will be done as external  therapy for  
3 days.  
The information I am collecting in this study will remain between you and the investigator 
(myself). If you wish to find out more about this study before taking part, you can ask me all the 
related questions about the study and contact me ( Dr. M. Lavanya, PG Scholar) through my mobile 
number 8508117010. You can also contact the Member - secretary of Ethics committee, National 
Institute Siddha, Chennai 600047, Tel no :91-44-22380789, for rights and participation in the study.  
 
Place                                                                                                    Signature of the investigator: 
Date               Name : 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
A CLINICAL EVALUATION OF CHUKKU NEI (INTERNAL) AND CHINNI 
THUVALAI (EXTERNAL) FOR KATTU MANTHAM (CONSTIPATION) IN 
CHILDREN. 
FORM VI  CLINICAL ASSESSMENT 
1. S.l. No: 2. OP/ IP No  : 3. Name: 
4. Age: 5. Gender   : 6. Date of Enrollment: 
7. Date of completion: 8. Informant : 9. Reliablity: 
 
 
 
 
 
Date  : ___________________     
Station : ___________                                                                             Signature of  Investigator 
S.NO CLINICAL 
FEATURES 
DAY   0 DAY 4 
YES NO YES NO 
 
    1 
 
  Constipation 
    
 
    2 
 
 Poor appetite 
    
 
   3 
 
Stomach pain / borborygmus 
    
 
   4 
 
Fever 
    
 
   5 
 
Cough 
    
 
   6 
 
Yawning 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
A CLINICAL EVALUATION OF CHUKKU NEI (INTERNAL) AND CHINNI 
THUVALAI (EXTERNAL) FOR KATTU MANTHAM (CONSTIPATION) IN 
CHILDREN. 
 
    FORM V – DRUG COMPLIANCE   
1. S.l. No: 2. OP/ IP No  : 3. Name: 
4. Age: 5. Gender   : 6. Date of Enrollment: 
7. Date of completion: 8. Informant : 9. Reliablity: 
 
NAME OF THE DRUG          :     CHUKKU NEI 
FORM OF THE DRUG          :     OIL 
ADMINISTRATION  :      PER ORAL 
DOSE AND DURATION :      5  ML (OD) FOR 3 DAYS 
 
 
 
 
 
 
 
Date:                                     
Station:       Signature of the Investigator: 
 
 
 
DAY     DATE    MORNING 
1   
2   
3   
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
A CLINICAL EVALUATION OF CHUKKU NEI (INTERNAL) AND CHINNI 
THUVALAI (EXTERNAL) FOR KATTU MANTHAM (CONSTIPATION) IN 
CHILDREN. 
FORM VII    WITHDRAWL FORM 
 
1. S.l. No: 2. OP/ IP No  : 3. Name: 
4. Age: 5. Gender: 6. Date of Enrollment: 
7. Date of completion: 8. Informant: 9. Reliablity: 
 
 
Date of trial commencement    : 
Date of withdrawal from trial   : 
Reason(s) for withdrawal   : Yes/ No  
Long absence at reporting   : Yes/ No 
Irregular treatment     : Yes/ No 
Shift of locality      : Yes/ No 
Complication adverse reactions if any : Yes/ No 
Exacerbation of symptoms   : Yes/ No 
 Patient not willing to continue             : Yes/ No 
 
Date:    Signature of Principal Investigator 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
              A CLINICAL EVALUATION OF CHUKKU NEI (INTERNAL) AND 
CHINNI THUVALAI (EXTERNAL) FOR KATTU MANTHAM (CONSTIPATION) 
IN CHILDREN. 
FORM VIII-ADVERSE REACTION 
 
1. S.l. No: 2. OP/ IP No  : 3. Name: 
4. Age: 5. Gender: 6. Date of Enrollment: 
7. Date of completion: 8. Informant: 9. Reliablity: 
 
 
Registration No    : 
Date of trial commencement  : 
Date of withdrawal from trial   : 
Description of adverse reaction  : 
 
 
 
 
 
 
 
Date:      Signature of Principal Investigator 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
              
A CLINICAL EVALUATION OF CHUKKU NEI (INTERNAL) AND CHINNI 
THUVALAI (EXTERNAL) FOR KATTU MANTHAM (CONSTIPATION) IN 
CHILDREN. 
FORM IX – PHARMACOVIGILANCE FORM 
 
1. Patient / consumer identification (please complete or tick boxes below as 
appropriate) 
NATIONAL PHARMACOVIGILANCE PROGRAMME FOR  SIDDHA DRUGS 
 
 
 
 
Please note:  i.All consumers / patients and reporters information will remain confidential. 
                        ii. It is requested to report all suspected reactions to the concerned, even                    
if it does not have complete data, as soon as possible. 
Peripheral Center code:     State:  
 
 
Name  Father name 
 
Patient / Record No. 
Ethnicity  Occupation 
Address  
Village / Town 
Post / Via 
District / State    
Date of Birth / Age: 
 
Sex:     Male / Female  
Weight : 
Degam: 
 
Reporting Form for Suspected Adverse Reactions to Siddha Drugs 
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2. Description of the suspected Adverse Reactions (please complete boxes below) 
 
Date and time  of 
initial observation 
 Season: 
Description of 
reaction   
 
 Geographical area: 
 
3. List of all medicines / Formulations including drugs of other systems used by the 
patient during the reporting period: 
 
Medicine Dail
y 
dose 
Route of 
administration 
& Vehicle – 
Adjuvant 
Date  Diagnosis for 
which medicine 
taken  
Starting Stopped 
Siddha 
 
     
Any other system 
of medicines 
 
     
 
4. Brief details of the Siddha Medicine which seems to be toxic : 
 
Details Drug – 1 Drug – 2 Drug - 3 
a) Name of the medicine    
b) Manufacturing unit and 
batch No. and date 
   
c) Expiry date    
d) Purchased and obtained 
from 
   
e) Composition of the 
formulation / Part of the drug 
used 
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b) Dietary Restrictions if any 
c) Whether the drug is consumed under Institutionally qualified medical supervision or used 
as self medication.  
d) Any other relevant information. 
 
5. Treatment provided for adverse reaction: 
 
6. The result  of the adverse reaction / side effect / untoward effects (please complete 
the boxes below) 
 
Recovered:           Not 
recovered: 
 Unknown: Fatal: If Fatal 
Date of death: 
Severe:   Yes   /   No. Reaction abated after drug stopped or dose reduced: 
 
Reaction reappeared after re introduction: 
 
 
Was the patient admitted to hospital? If 
yes, give name and address of hospital 
 
 
7. Any laboratory investigations done to evaluate other possibilities?  If Yes specify:  
 
8. Whether the patient is suffering with any chronic disorders? 
Hepatic    Renal    Cardiac    Diabetes    Malnutrition  
Any Others  
 
 
9. H/O previous allergies / Drug reactions:  
 
10. Other illness (please describe): 
 
11. Identification of the reporter: 
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Type (please tick):  Nurse / Doctor / Pharmacist / Health worker / Patient / Attendant / 
Manufacturer /                                                                      
                                Distributor / Supplier / Any others (please specify) 
Name: 
 
Address: 
 
Telephone / E – mail if any : 
 
 
 
 
 
 
Signature of the reporter:       Date: 
 
 
 
Please send the completed form to:  
     The Director 
      National Institute of Siddha, 
(Pharmacovigilance Regional  Centre For Siddha Medicine), 
                                                           Tambaram Sanatorium, Chennai-600 047. 
 (O) 044-22381314   Fax : 044 – 22381314  
 Website :www.nischennai.org 
 Email: nischennaisiddha@yahoo.co.in 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * ** * * * * 
This filled-in ADR report may be sent within one month of observation /occurrence of 
ADR   
 
 
 
   
Who Can Report?     
 Any Health care professionals like Siddha Doctors /  Nurses / Siddha Pharmacists / 
Patients etc.  
What to Report?  
 All reactions,  Drug interactions,  
Confidentiality 
 The patient‟s identity will be held in strict confidence and protected to the fullest 
extent.  
 Submission of report will be taken up for remedial measures only not for legal claim  
Name & address of the RRC-
ASU/ PPC-ASU 
 
 
129 
  
 
 
 
 
130 
  
NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF KUZHANDHAI MARUTHUVAM 
A CLINICAL EVALUATION OF CHUKKU NEI (INTERNAL) AND CHINNI 
THUVALAI (EXTERNAL) FOR KATTU MANTHAM (CONSTIPATION) IN 
CHILDREN. 
 
FORM IX-DIETARY ADVICE FORM 
 THINGS TO TAKE  THINGS TO AVOID 
Fruits-Fig,Papaya,Gauva,Grapes,Bananas, 
apples, orange,dates 
 
Refridged items 
 
All greens eg-palak Tin and canned  foods 
 
Fresh vegetable soups Cream containing biscuits and cakes 
 
Boiled water Junk and fast foods 
 
Fiber rich foods eg-whole-grain breads and 
cereals,almonds,legumes 
 
White sugar, Maida 
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